Brian H Dovey - Insider Trading Tracker

एडिनक्स, इंक.

US ˙ OTCPK ˙ US00784D1037

परिचय

यह पृष्ठ Brian H Dovey के ज्ञात इनसाइडर व्यापार इतिहास का व्यापक विश्लेषण प्रदान करता है। इनसाइडर किसी कंपनी के अधिकारी, निदेशक या महत्वपूर्ण निवेशक होते हैं। इनसाइडर के लिए विशिष्ट, गैर-सार्वजनिक जानकारी के आधार पर अपनी कंपनियों में व्यापार करना गैरकानूनी है। इसका मतलब यह नहीं है कि उनके लिए अपनी कंपनियों में कोई भी व्यापार करना गैरकानूनी है। हालाँकि, उन्हें फॉर्म 4 के माध्यम से SEC को सभी ट्रेड्स की रिपोर्ट करनी होगी। इन प्रतिबंधों के बावजूद, अकादमिक शोध से पता चलता है कि इनसाइडर - सामान्य तौर पर - अपनी कंपनियों में बाजार से बेहतर प्रदर्शन करते हैं।

औसत व्यापार लाभप्रदता

औसत ट्रेड लाभप्रदता पिछले तीन वर्षों में इनसाइडर द्वारा की गई सभी खुले बाजार खरीद का औसत रिटर्न है। इसकी गणना करने के लिए, हम 10b5-1 ट्रेडिंग योजना के हिस्से के रूप में चिह्नित सभी ट्रेडों को छोड़कर, इनसाइडर द्वारा की गई प्रत्येक खुले बाजार, अनियोजित खरीदारी की जांच करते हैं। फिर हम 3, 6 और 12 महीनों में उन ट्रेडों के औसत प्रदर्शन की गणना करते हैं, प्रत्येक ट्रेड के लिए अंतिम प्रदर्शन मीट्रिक तैयार करने के लिए उनमें से प्रत्येक अवधि का औसत निकालते हैं। अंत में, हम इनसाइडर के लिए प्रदर्शन मीट्रिक की गणना करने के लिए सभी प्रदर्शन मीट्रिक का औसत निकालते हैं। इस सूची में केवल उन इनसाइडर को शामिल किया गया है जिन्होंने पिछले दो वर्षों में कम से कम तीन ट्रेड किए हैं।

यदि इस इनसाइडर ट्रेड की लाभप्रदता "N/A" है, तो इनसाइडर ने या तो पिछले तीन वर्षों में कोई खुले बाजार में खरीदारी नहीं की है, या उनके द्वारा किए गए व्यापार एक विश्वसनीय प्रदर्शन मीट्रिक की गणना करने के लिए बहुत हाल के हैं।

अपडेट फ्रीक्वेंसी: दैनिक

सर्वाधिक लाभदायक इनसाइडर व्यापारियों की सूची देखें।

उच्चतम रैंकिंग वाले इनसाइडर देखें

रिपोर्ट की गई इनसाइडर स्थिति वाली कंपनियाँ

SEC फाइलिंग से संकेत मिलता है कि Brian H Dovey ने निम्नलिखित कंपनियों में होल्डिंग्स या ट्रेड्स की सूचना दी है:

प्रतिभूति	टाइटल	नवीनतम रिपोर्ट की गई होल्डिंग्स
US:RVA / REVA Medical, Inc.	Director	0
	10% Owner	187,500
US:ADYX / Adynxx, Inc.	10% Owner	45,054
US:BNGO / Bionano Genomics, Inc.	10% Owner	15,000
US:DRNA / Dicerna Pharmaceuticals Inc	10% Owner	0
US:OCRX / Ocera Therapeutics, Inc.	10% Owner	0
US:OREX / Orexigen Therapeutics, Inc.	Director	5,000
US:TBRA / Tobira Therapeutics, Inc.	10% Owner	0
US:CLCD / CoLucid Pharmaceuticals, Inc.	10% Owner	0
US:EVOK / Evoke Pharma, Inc.	10% Owner	10,328
US:SNDX / Syndax Pharmaceuticals, Inc.	10% Owner	0
US:GKOS / Glaukos Corporation	10% Owner	0
US:OTIC / Otonomy Inc	Director	32,745
US:LIFE / aTyr Pharma, Inc.	10% Owner	0
US:ESPR / Esperion Therapeutics, Inc.	10% Owner	2,216,935
US:NEOT / Neothetics, Inc.	10% Owner	0
US:DRTX / Durata Therapeutics Inc	10% Owner	0
US:ATRA / Atara Biotherapeutics, Inc.	10% Owner	0
US:VCYT / Veracyte, Inc.	10% Owner	2,763,294
US:MRNS / Marinus Pharmaceuticals, Inc.	10% Owner	0
US:ALDX / Aldeyra Therapeutics, Inc.	10% Owner	0
	10% Owner	0
US:AKAO / Achaogen, Inc.	10% Owner	0
US:ALIM / Alimera Sciences, Inc.	10% Owner	34,907
US:TNDM / Tandem Diabetes Care, Inc.	10% Owner	6,008
US:CLVS / Clovis Oncology Inc	10% Owner	2,581,745
	10% Owner	159,896
	10% Owner	2,222,175

चार्ट को कैसे समझे

निम्नलिखित चार्ट Brian H Dovey द्वारा किए गए प्रत्येक खुले-बाज़ार, गैर-योजनाबद्ध व्यापार के बाद प्रतिभूतियों के स्टॉक प्रदर्शन को दर्शाते हैं। गैर-योजनाबद्ध व्यापार वे व्यापार हैं जो 10b5-1 ट्रेडिंग योजना के हिस्से के रूप में नहीं किए गए थे। स्टॉक प्रदर्शन को शेयर मूल्य में संचयी प्रतिशत परिवर्तन के रूप में चार्ट किया गया है। उदाहरण के लिए, यदि कोई इनसाइडर व्यापार 1 जनवरी, 2019 को किया गया था, तो चार्ट आज तक प्रतिभूति में दैनिक प्रतिशत परिवर्तन दिखाएगा। यदि इस दौरान शेयर की कीमत $10 से $15 तक जाती है, तो शेयर की कीमत में संचयी प्रतिशत परिवर्तन 50% होगा। $10 से $20 तक की कीमत में परिवर्तन 100% होगा, और $10 से $5 की कीमत में परिवर्तन -50% होगा।

अंततः, हम यह निर्धारित करने का प्रयास कर रहे हैं कि इनसाइडर के व्यापार शेयर की कीमत में अतिरिक्त रिटर्न (सकारात्मक या नकारात्मक) से कितनी निकटता से संबंधित हैं, यह देखने के लिए कि क्या इनसाइडर, इनसाइडर जानकारी से लाभ के लिए अपने व्यापार का समय निर्धारित कर रहे हैं। उस स्थिति पर विचार करें जहां कोई इनसाइडर ऐसा कर रहा था। इस स्थिति में, हम या तो (a) खरीदारी के बाद सकारात्मक रिटर्न, या (a) बिक्री के बाद नकारात्मक रिटर्न की उम्मीद करेंगे। (a) के मामले में, खरीद चार्ट ऊपर की ओर झुके हुए वक्रों की एक श्रृंखला दिखाएगा, जो प्रत्येक खरीद लेनदेन के बाद सकारात्मक रिटर्न का संकेत देगा। (a) के मामले में, बिक्री चार्ट नीचे की ओर झुके हुए वक्रों की एक श्रृंखला दिखाएगा, जो प्रत्येक बिक्री लेनदेन के बाद नकारात्मक रिटर्न का संकेत देगा।

हालाँकि, केवल यह निष्कर्ष निकालने के लिए पर्याप्त नहीं है। यदि, उदाहरण के लिए, कंपनी का शेयर मूल्य कई वर्षों से गैर-चक्रीय चढ़ाई में था, तो हम उम्मीद करेंगे कि खरीद के बाद के सभी प्लॉट ऊपर की ओर झुके हुए होंगे। इसी तरह, कई वर्षों में गैर-चक्रीय गिरावट के परिणामस्वरूप व्यापार के बाद के प्लॉट नीचे की ओर झुकेंगे। इनमें से कोई भी चार्ट इनसाइडर व्यापार गतिविधि का सुझाव नहीं देगा।

सबसे मजबूत संकेतक वह स्थिति होगी जहां शेयर की कीमत बेहद चक्रीय थी, और खरीद चार्ट में सकारात्मक संकेत और बिक्री चार्ट पर नकारात्मक प्लॉट दोनों थे। यह स्थिति एक इनसाइडर के लिए अत्यधिक संकेत देने वाली होगी जो अपने वित्तीय लाभ के लिए ट्रेड्स का समय निर्धारित कर रहा था।

इनसाइडर खरीदारी ADYX / Adynxx, Inc. - अल्पकालिक लाभ विश्लेषण

इस अनुभाग में, हम ADYX / Adynxx, Inc. में की गई प्रत्येक अनियोजित, खुले बाज़ार की इनसाइडर खरीदारी की लाभप्रदता का विश्लेषण करते हैं। यह विश्लेषण यह समझने में मदद करता है कि क्या इनसाइडर लगातार असामान्य रिटर्न उत्पन्न करता है, और यह अनुसरण करने लायक है। यह विश्लेषण प्रत्येक व्यापार के बाद एक वर्ष के लिए है, और परिणाम सैद्धांतिक हैं।

निम्न तालिका सबसे हालिया खुले बाज़ार की खरीदारी को दर्शाती है जो स्वचालित ट्रेडिंग योजना का हिस्सा नहीं थी।

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

समायोजित कीमत विभाजित-समायोजित कीमत है। समायोजित शेयर विभाजित-समायोजित शेयर हैं।

इनसाइडर बिक्री ADYX / Adynxx, Inc. - अल्पकालिक हानि विश्लेषण

इस अनुभाग में, हम ADYX / Adynxx, Inc. में की गई प्रत्येक अनियोजित, खुले बाज़ार की इनसाइडर बिक्री के अल्पकालिक नुकसान से बचने का विश्लेषण करते हैं। हानि से बचने का एक सुसंगत पैटर्न यह सुझाव दे सकता है कि भविष्य में बिक्री लेनदेन कीमत में गिरावट की भविष्यवाणी कर सकते हैं। यह विश्लेषण प्रत्येक व्यापार के बाद एक वर्ष के लिए है, और परिणाम सैद्धांतिक हैं।

निम्न तालिका सबसे हालिया खुले बाज़ार की बिक्री को दर्शाती है जो स्वचालित ट्रेडिंग योजना का हिस्सा नहीं थी।

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी ALDX / Aldeyra Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

ALDX / Aldeyra Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री ALDX / Aldeyra Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी ATRA / Atara Biotherapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2014-10-21	ATRA	DP VIII Associates, L.P.	1,841	11.0000	74	275.0000	20,251	184	1600.5	96,586	476.94
2014-10-21	ATRA	Domain Partners VIII, L.P.	248,159	11.0000	9,926	275.0000	2,729,749

ATRA / Atara Biotherapeutics, Inc. Insider Trades

इनसाइडर बिक्री ATRA / Atara Biotherapeutics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी ATYR / aTyr Pharma, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर बिक्री ATYR / aTyr Pharma, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी BNGO / Bionano Genomics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2018-08-23	BNGO	Domain Partners VIII, L.P.	15,000	6.1250	429	214.3750	91,875	35	82.5	-56,565	-61.57

BNGO / Bionano Genomics, Inc. Insider Trades

इनसाइडर बिक्री BNGO / Bionano Genomics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी ESPR / Esperion Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2014-10-21	ESPR	DOMAIN PARTERS VII L P	500,000	20.0000	500,000	20.0000	10,000,000	210	115.3000	47,650,000	476.50

ESPR / Esperion Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री ESPR / Esperion Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी EVOK / Evoke Pharma, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

EVOK / Evoke Pharma, Inc. Insider Trades

इनसाइडर बिक्री EVOK / Evoke Pharma, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2016-05-26	EVOK	DP VII ASSOCIATES LP	5,880	4.7000	490	56.4000	27,636	203	17.28	-19,169	-69.36
2016-05-26	EVOK	DOMAIN PARTERS VII L P	344,120	4.7000	28,677	56.4000	1,617,364
2016-04-27	EVOK	DP VII ASSOCIATES LP	61	5.0200	5	60.2400	306
2016-04-27	EVOK	DOMAIN PARTERS VII L P	3,603	5.0200	300	60.2400	18,087
2016-04-25	EVOK	DP VII ASSOCIATES LP	21	5.2000	2	62.4000	109
2016-04-25	EVOK	DOMAIN PARTERS VII L P	1,492	5.2000	124	62.4000	7,758
2016-04-20	EVOK	DP VII ASSOCIATES LP	76	5.2900	6	63.4800	402
2016-04-20	EVOK	DOMAIN PARTERS VII L P	4,424	5.2900	369	63.4800	23,403
2016-04-19	EVOK	DP VII ASSOCIATES LP	632	5.3600	53	64.3200	3,388
2016-04-19	EVOK	DOMAIN PARTERS VII L P	37,054	5.3600	3,088	64.3200	198,609
2016-04-11	EVOK	DP VII ASSOCIATES LP	75	5.2200	6	62.6400	392
2016-04-11	EVOK	DOMAIN PARTERS VII L P	4,348	5.2200	362	62.6400	22,697
2016-04-08	EVOK	DP VII ASSOCIATES LP	251	5.3500	21	64.2000	1,343
2016-04-08	EVOK	DOMAIN PARTERS VII L P	14,554	5.3500	1,213	64.2000	77,864
2016-04-07	EVOK	DP VII ASSOCIATES LP	475	5.2600	40	63.1200	2,498
2016-04-07	EVOK	DOMAIN PARTERS VII L P	27,781	5.2600	2,315	63.1200	146,128
2016-04-06	EVOK	DP VII ASSOCIATES LP	148	5.2200	12	62.6400	773
2016-04-06	EVOK	DOMAIN PARTERS VII L P	8,669	5.2200	722	62.6400	45,252
2015-08-18	EVOK	DOMAIN PARTERS VII L P	11,836	7.0200	986	84.2400	83,089
2015-08-18	EVOK	DP VII ASSOCIATES LP	202	7.0200	17	84.2400	1,418
2015-04-16	EVOK	DOMAIN PARTERS VII L P	32,411	7.0700	2,701	84.8400	229,146
2015-04-16	EVOK	DP VII ASSOCIATES LP	554	7.0700	46	84.8400	3,917
2015-04-15	EVOK	DOMAIN PARTERS VII L P	7,920	7.5800	660	90.9600	60,034
2015-04-15	EVOK	DP VII ASSOCIATES LP	135	7.5800	11	90.9600	1,023
2015-04-14	EVOK	DOMAIN PARTERS VII L P	9,832	7.7800	819	93.3600	76,493
2015-04-14	EVOK	DP VII ASSOCIATES LP	168	7.7800	14	93.3600	1,307

इनसाइडर खरीदारी GKOS / Glaukos Corporation - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

GKOS / Glaukos Corporation Insider Trades

इनसाइडर बिक्री GKOS / Glaukos Corporation - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी SNDX / Syndax Pharmaceuticals, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

SNDX / Syndax Pharmaceuticals, Inc. Insider Trades

इनसाइडर बिक्री SNDX / Syndax Pharmaceuticals, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी VCYT / Veracyte, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर बिक्री VCYT / Veracyte, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर व्यापार इतिहास

यह तालिका सिक्योरिटीज एक्सचेंज कमीशन (SEC) को बताए अनुसार Brian H Dovey द्वारा किए गए इनसाइडर व्यापारों की पूरी सूची दिखाती है।

फ़ाइल तिथि	ट्रांजेक्शन तिथि	फॉर्म	टिकर	प्रतिभूति	कोड	10b5-1	शेयर	शेष शेयर	प्रतिशत परिवर्तन	शेयर कीमत	ट्रांजेक्शन वैल्यू	शेष मूल्य
2019-11-13	2019-11-11	4	RVA	REVA Medical, Inc. Common Stock	S - Sale		-85,186	0	-100.00
2019-11-13	2019-11-11	4	RVA	REVA Medical, Inc. Common Stock	S - Sale		-3,606,002	0	-100.00
2019-11-13	2019-11-11	4	RVA	REVA Medical, Inc. Common Stock	S - Sale		-15,500	0	-100.00	0.00	-2
2019-11-13	2019-11-11	4	RVA	REVA Medical, Inc. Common Stock	S - Sale		-15,500	0	-100.00	0.00	-2
2019-08-08	2019-08-06	4	OBLN	OBALON THERAPEUTICS INC Warrants to Purchase Common Stock	P - Purchase		187,500	187,500		4.00	750,000	750,000
2019-08-08	2019-08-06	4	OBLN	OBALON THERAPEUTICS INC Common Stock	P - Purchase		250,000	813,433	44.37	4.00	1,000,000	3,253,732
2019-05-13		3	ADYX	Alliqua BioMedical, Inc. Common Stock				45,054
2019-05-13		3	ADYX	Alliqua BioMedical, Inc. Common Stock				45,054
2019-05-13		3	ADYX	Alliqua BioMedical, Inc. Common Stock				45,054
2019-05-13		3	ADYX	Alliqua BioMedical, Inc. Common Stock				45,054
2019-05-13		3	ADYX	Alliqua BioMedical, Inc. Common Stock				45,054
2019-05-13		3	ADYX	Alliqua BioMedical, Inc. Common Stock				45,054
2019-05-13		3	ADYX	Alliqua BioMedical, Inc. Common Stock				45,054
2019-05-13		3	ADYX	Alliqua BioMedical, Inc. Common Stock				45,054
2019-05-13		3	ADYX	Alliqua BioMedical, Inc. Common Stock				6,072,088
2019-05-13		3	ADYX	Alliqua BioMedical, Inc. Common Stock				6,072,088
2019-05-13		3	ADYX	Alliqua BioMedical, Inc. Common Stock				6,072,088
2019-05-13		3	ADYX	Alliqua BioMedical, Inc. Common Stock				6,072,088
2019-05-13		3	ADYX	Alliqua BioMedical, Inc. Common Stock				6,072,088
2019-05-13		3	ADYX	Alliqua BioMedical, Inc. Common Stock				6,072,088
2019-05-13		3	ADYX	Alliqua BioMedical, Inc. Common Stock				6,072,088
2019-05-13		3	ADYX	Alliqua BioMedical, Inc. Common Stock				6,072,088
2018-08-27	2018-08-23	4	BNGO	BioNano Genomics, Inc Warrants to Purchase Common Stock	P - Purchase		15,000	15,000
2018-08-27	2018-08-23	4	BNGO	BioNano Genomics, Inc Series B Preferred Stock	C - Conversion		-6,810,098	0	-100.00
2018-08-27	2018-08-23	4	BNGO	BioNano Genomics, Inc Convertible Promissory Note	C - Conversion			0
2018-08-27	2018-08-23	4	BNGO	BioNano Genomics, Inc Series D-1 Preferred Stock	C - Conversion		-3,682,919	0	-100.00
2018-08-27	2018-08-23	4	BNGO	BioNano Genomics, Inc Series D Preferred Stock	C - Conversion		-6,396,105	0	-100.00
2018-08-27	2018-08-23	4	BNGO	BioNano Genomics, Inc Series C Preferred Stock	C - Conversion		-5,426,808	0	-100.00
2018-08-27	2018-08-23	4	BNGO	BioNano Genomics, Inc Series B-1 Preferred Stock	C - Conversion		-2,986,762	0	-100.00
2018-08-27	2018-08-23	4	BNGO	BioNano Genomics, Inc Common Stock	P - Purchase		15,000	943,878	1.61	6.12	91,875	5,781,253
2018-08-27	2018-08-23	4	BNGO	BioNano Genomics, Inc Common Stock	C - Conversion		337,694	929,878	57.03	4.59	1,550,015	4,268,140
2018-08-27	2018-08-23	4	BNGO	BioNano Genomics, Inc Common Stock	C - Conversion		591,184	591,184
2018-08-27	2018-08-23	4	BNGO	BioNano Genomics, Inc Series B Preferred Stock	C - Conversion		-50,532	0	-100.00
2018-08-27	2018-08-23	4	BNGO	BioNano Genomics, Inc Convertible Promissory Note	C - Conversion			0
2018-08-27	2018-08-23	4	BNGO	BioNano Genomics, Inc Series D-1 Preferred Stock	C - Conversion		-27,328	0	-100.00
2018-08-27	2018-08-23	4	BNGO	BioNano Genomics, Inc Series D Preferred Stock	C - Conversion		-47,460	0	-100.00
2018-08-27	2018-08-23	4	BNGO	BioNano Genomics, Inc Series C Preferred Stock	C - Conversion		-40,268	0	-100.00
2018-08-27	2018-08-23	4	BNGO	BioNano Genomics, Inc Series B-1 Preferred Stock	C - Conversion		-22,161	0	-100.00
2018-08-27	2018-08-23	4	BNGO	BioNano Genomics, Inc Common Stock	C - Conversion		2,505	6,891	57.11	4.59	11,498	31,630
2018-08-27	2018-08-23	4	BNGO	BioNano Genomics, Inc Common Stock	C - Conversion		4,386	4,386
2018-08-27	2018-08-23	4	OBLN	OBALON THERAPEUTICS INC Common Stock	P - Purchase		1,648,359	5,634,329	41.35	1.82	3,000,013	10,254,479
2018-08-21		3	BNGO	BioNano Genomics, Inc Common Stock				280
2018-08-21		3	BNGO	BioNano Genomics, Inc Common Stock				280
2018-08-21		3	BNGO	BioNano Genomics, Inc Common Stock				280
2018-08-21		3	BNGO	BioNano Genomics, Inc Common Stock				280
2018-08-21		3	BNGO	BioNano Genomics, Inc Common Stock				280
2018-08-21		3	BNGO	BioNano Genomics, Inc Common Stock				280
2018-08-21		3	BNGO	BioNano Genomics, Inc Common Stock				280
2018-08-21		3	BNGO	BioNano Genomics, Inc Common Stock				280
2018-07-03	2018-06-29	4	RVA	REVA Medical, Inc. Common Stock	J - Other		3,000	15,500	24.00
2018-07-03	2018-06-29	4	RVA	REVA Medical, Inc. Common Stock	J - Other		-3,000	15,500	-16.22
2018-05-18	2018-05-16	4	RVA	REVA Medical, Inc. Stock Option (Right to Buy)	A - Award		25,000	25,000
2017-12-20	2017-12-18	4	DRNA	Dicerna Pharmaceuticals Inc Redeemable Convertible Preferred Stock	C - Conversion		-368	0	-100.00
2017-12-20	2017-12-18	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	A - Award		282	25,730	1.11
2017-12-20	2017-12-18	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	C - Conversion		12,444	25,448	95.69	3.19	39,696	81,179
2017-12-20	2017-12-18	4	DRNA	Dicerna Pharmaceuticals Inc Redeemable Convertible Preferred Stock	C - Conversion		-49,632	0	-100.00
2017-12-20	2017-12-18	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	A - Award		37,890	3,469,029	1.10
2017-12-20	2017-12-18	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	C - Conversion		1,678,432	3,431,139	95.76	3.19	5,354,198	10,945,333
2017-12-13	2017-12-11	4	OCRX	Ocera Therapeutics, Inc. Common Stock	D - Sale to Issuer		-988,285	0	-100.00
2017-12-13	2017-12-11	4	OCRX	Ocera Therapeutics, Inc. Common Stock	D - Sale to Issuer		-47,963	0	-100.00
2017-12-13	2017-12-11	4	OCRX	Ocera Therapeutics, Inc. Common Stock	D - Sale to Issuer		-15,731	0	-100.00
2017-12-13	2017-12-11	4	OCRX	Ocera Therapeutics, Inc. Warrant to Purchase Common Stock	D - Sale to Issuer		-20,150	0	-100.00
2017-12-13	2017-12-11	4	OCRX	Ocera Therapeutics, Inc. Warrant to Purchase Common Stock	D - Sale to Issuer		-20,150	0	-100.00
2017-12-13	2017-12-11	4	OCRX	Ocera Therapeutics, Inc. Common Stock	D - Sale to Issuer		-1,857,036	0	-100.00
2017-12-13	2017-12-11	4	OCRX	Ocera Therapeutics, Inc. Common Stock	D - Sale to Issuer		-7,333	0	-100.00
2017-07-27	2017-07-25	4	RVA	REVA Medical, Inc. Common Stock	J - Other		5,000	12,500	66.67
2017-07-27	2017-07-25	4	RVA	REVA Medical, Inc. Common Stock	J - Other		-5,000	18,500	-21.28
2017-07-18	2017-07-14	4	OREX	Orexigen Therapeutics, Inc. Stock Option (Right to Buy)	A - Award		5,000	5,000
2017-07-11	2017-07-09	4	RVA	REVA Medical, Inc. Stock Option (Right to Buy)	A - Award		10,500	10,500
2017-07-11	2017-07-09	4	RVA	REVA Medical, Inc. Common Stock	A - Award		6,000	23,500	34.29
2017-04-12	2017-04-11	4	DRNA	Dicerna Pharmaceuticals Inc Redeemable Convertible Preferred Stock	P - Purchase		49,632	49,632		100.00	4,963,200	4,963,200
2017-04-12	2017-04-11	4	DRNA	Dicerna Pharmaceuticals Inc Redeemable Convertible Preferred Stock	P - Purchase		368	368		100.00	36,800	36,800
2016-11-04	2016-11-01	4	TBRA	Tobira Therapeutics, Inc. Stock Option (Right to Buy)	D - Sale to Issuer		17,695	0	-100.00
2016-11-04	2016-11-01	4	TBRA	Tobira Therapeutics, Inc. Stock Option (Right to Buy)	D - Sale to Issuer		1,071	0	-100.00
2016-11-04	2016-11-01	4	TBRA	Tobira Therapeutics, Inc. Stock Option (Right to Buy)	D - Sale to Issuer		1,996	0	-100.00
2016-11-04	2016-11-01	4	TBRA	Tobira Therapeutics, Inc. Common Stock	U - Other		-38,094	0	-100.00	28.35	-1,079,965
2016-11-03	2016-11-01	4	TBRA	Tobira Therapeutics, Inc. Common Stock	U - Other		-3,553,322	0	-100.00	28.35	-100,736,679
2016-11-03	2016-11-01	4	TBRA	Tobira Therapeutics, Inc. Common Stock	U - Other		-47,613	0	-100.00	28.35	-1,349,829
2016-11-03	2016-11-01	4	TBRA	Tobira Therapeutics, Inc. Common Stock	U - Other		-1,657	0	-100.00	28.35	-46,976
2016-11-03	2016-11-01	4	TBRA	Tobira Therapeutics, Inc. Common Stock	U - Other		-285,679	0	-100.00	28.35	-8,099,000
2016-10-14	2016-10-12	4	OBLN	OBALON THERAPEUTICS INC Series C Preferred Stock	C - Conversion		-14,271	0	-100.00
2016-10-14	2016-10-12	4	OBLN	OBALON THERAPEUTICS INC Series B Preferred Stock	C - Conversion		-20,583	0	-100.00
2016-10-14	2016-10-12	4	OBLN	OBALON THERAPEUTICS INC Series A Preferred Stock	C - Conversion		-11,083	0	-100.00
2016-10-14	2016-10-12	4	OBLN	OBALON THERAPEUTICS INC Common Stock	C - Conversion		49,570	49,570
2016-10-14	2016-10-12	4	OBLN	OBALON THERAPEUTICS INC Series E Preferred Stock	C - Conversion		-482,326	0	-100.00
2016-10-14	2016-10-12	4	OBLN	OBALON THERAPEUTICS INC Series D Preferred Stock	C - Conversion		-597,207	0	-100.00
2016-10-14	2016-10-12	4	OBLN	OBALON THERAPEUTICS INC Series C Preferred Stock	C - Conversion		-836,722	0	-100.00
2016-10-14	2016-10-12	4	OBLN	OBALON THERAPEUTICS INC Series B Preferred Stock	C - Conversion		-1,206,836	0	-100.00
2016-10-14	2016-10-12	4	OBLN	OBALON THERAPEUTICS INC Series A Preferred Stock	C - Conversion		-649,835	0	-100.00
2016-10-14	2016-10-12	4	OBLN	OBALON THERAPEUTICS INC Common Stock	C - Conversion		3,985,970	3,985,970
2016-09-13	2016-09-09	4	CLCD	CoLucid Pharmaceuticals, Inc. Common Stock	J - Other		-1,943,109	0	-100.00
2016-08-03	2016-08-03	4	CLCD	CoLucid Pharmaceuticals, Inc. Common Stock	S - Sale		-129	3,039	-4.07	8.15	-1,051	24,768
2016-08-03	2016-08-02	4	CLCD	CoLucid Pharmaceuticals, Inc. Common Stock	S - Sale		-32	3,168	-1.00	8.71	-279	27,593
2016-08-03	2016-08-01	4	CLCD	CoLucid Pharmaceuticals, Inc. Common Stock	S - Sale		-84	3,200	-2.56	8.82	-741	28,224
2016-08-03	2016-08-03	4	CLCD	CoLucid Pharmaceuticals, Inc. Common Stock	S - Sale		-81,094	1,943,109	-4.01	8.15	-660,916	15,836,338
2016-08-03	2016-08-02	4	CLCD	CoLucid Pharmaceuticals, Inc. Common Stock	S - Sale		-19,718	2,024,203	-0.96	8.71	-171,744	17,630,808
2016-08-03	2016-08-01	4	CLCD	CoLucid Pharmaceuticals, Inc. Common Stock	S - Sale		-52,216	2,043,921	-2.49	8.82	-460,545	18,027,383
2016-08-01	2016-08-01	4	RVA	REVA Medical, Inc. Common Stock	J - Other		7,500	7,500
2016-08-01	2016-08-01	4	RVA	REVA Medical, Inc. Common Stock	J - Other		-7,500	17,500	-30.00
2016-07-14	2016-07-12	4	OREX	Orexigen Therapeutics, Inc. Stock Option (Right to Buy)	A - Award		15,000	15,000
2016-05-27	2016-05-25	4	RVA	REVA Medical, Inc. Stock Option (Right to Buy)	A - Award		11,800	11,800
2016-05-27	2016-05-25	4	RVA	REVA Medical, Inc. Common Stock	A - Award		10,000	25,000	66.67
2016-05-27	2016-05-26	4	EVOK	Evoke Pharma Inc Common Stock	S - Sale		-5,880	10,328	-36.28	4.70	-27,636	48,542
2016-05-27	2016-05-26	4	EVOK	Evoke Pharma Inc Common Stock	S - Sale		-344,120	606,283	-36.21	4.70	-1,617,364	2,849,530
2016-05-02	2016-04-28	4	CLCD	CoLucid Pharmaceuticals, Inc. Common Stock	S - Sale		-149,765	2,096,137	-6.67	6.96	-1,042,364	14,589,114
2016-05-02	2016-04-28	4	CLCD	CoLucid Pharmaceuticals, Inc. Common Stock	S - Sale		-235	3,284	-6.68	6.96	-1,636	22,857
2016-04-27	2016-04-27	4	EVOK	Evoke Pharma Inc Common Stock	S - Sale		-61	16,208	-0.37	5.02	-306	81,364
2016-04-27	2016-04-25	4	EVOK	Evoke Pharma Inc Common Stock	S - Sale		-21	16,269	-0.13	5.20	-109	84,599
2016-04-27	2016-04-27	4	EVOK	Evoke Pharma Inc Common Stock	S - Sale		-3,603	950,403	-0.38	5.02	-18,087	4,771,023
2016-04-27	2016-04-25	4	EVOK	Evoke Pharma Inc Common Stock	S - Sale		-1,492	954,006	-0.16	5.20	-7,758	4,960,831
2016-04-21	2016-04-20	4	EVOK	Evoke Pharma Inc Common Stock	S - Sale		-76	16,290	-0.46	5.29	-402	86,174
2016-04-21	2016-04-19	4	EVOK	Evoke Pharma Inc Common Stock	S - Sale		-632	16,366	-3.72	5.36	-3,388	87,722
2016-04-21	2016-04-20	4	EVOK	Evoke Pharma Inc Common Stock	S - Sale		-4,424	955,498	-0.46	5.29	-23,403	5,054,584
2016-04-21	2016-04-19	4	EVOK	Evoke Pharma Inc Common Stock	S - Sale		-37,054	959,922	-3.72	5.36	-198,609	5,145,182
2016-04-13	2016-04-11	4	EVOK	Evoke Pharma Inc Common Stock	S - Sale		-75	16,998	-0.44	5.22	-392	88,730
2016-04-13	2016-04-11	4	EVOK	Evoke Pharma Inc Common Stock	S - Sale		-4,348	996,976	-0.43	5.22	-22,697	5,204,215
2016-04-08	2016-04-08	4	EVOK	Evoke Pharma Inc Common Stock	S - Sale		-251	17,073	-1.45	5.35	-1,343	91,341
2016-04-08	2016-04-07	4	EVOK	Evoke Pharma Inc Common Stock	S - Sale		-475	17,324	-2.67	5.26	-2,498	91,124
2016-04-08	2016-04-06	4	EVOK	Evoke Pharma Inc Common Stock	S - Sale		-148	17,799	-0.82	5.22	-773	92,911
2016-04-08	2016-04-08	4	EVOK	Evoke Pharma Inc Common Stock	S - Sale		-14,554	1,001,324	-1.43	5.35	-77,864	5,357,083
2016-04-08	2016-04-07	4	EVOK	Evoke Pharma Inc Common Stock	S - Sale		-27,781	1,015,878	-2.66	5.26	-146,128	5,343,518
2016-04-08	2016-04-06	4	EVOK	Evoke Pharma Inc Common Stock	S - Sale		-8,669	1,043,659	-0.82	5.22	-45,252	5,447,900
2016-03-08	2016-03-08	4	SNDX	Syndax Pharmaceuticals Inc Series C-1 Preferred Stock	C - Conversion		-360,640	0	-100.00
2016-03-08	2016-03-08	4	SNDX	Syndax Pharmaceuticals Inc Series B-1 Preferred Stock	C - Conversion		-400,422	0	-100.00
2016-03-08	2016-03-08	4	SNDX	Syndax Pharmaceuticals Inc Common Stock	C - Conversion		761,062	761,062
2016-03-08	2016-03-08	4	SNDX	Syndax Pharmaceuticals Inc Series C-1 Preferred Stock	C - Conversion		-2,674	0	-100.00
2016-03-08	2016-03-08	4	SNDX	Syndax Pharmaceuticals Inc Series B-1 Preferred Stock	C - Conversion		-2,967	0	-100.00
2016-03-08	2016-03-08	4	SNDX	Syndax Pharmaceuticals Inc Common Stock	C - Conversion		5,641	5,641
2016-03-08	2016-03-08	4	SNDX	Syndax Pharmaceuticals Inc Series A-1 Preferred Stock	C - Conversion		-13,925	0	-100.00
2016-03-08	2016-03-08	4	SNDX	Syndax Pharmaceuticals Inc Common Stock	C - Conversion		13,925	13,925
2016-03-08	2016-03-08	4	SNDX	Syndax Pharmaceuticals Inc Series B-1 Preferred Stock	C - Conversion		-444,460	0	-100.00
2016-03-08	2016-03-08	4	SNDX	Syndax Pharmaceuticals Inc Series A-1 Preferred Stock	C - Conversion		-1,299,394	0	-100.00
2016-03-08	2016-03-08	4	SNDX	Syndax Pharmaceuticals Inc Common Stock	C - Conversion		1,743,854	1,743,854
2016-03-02		3	SNDX	Syndax Pharmaceuticals Inc Common Stock				27,128
2016-03-02		3	SNDX	Syndax Pharmaceuticals Inc Common Stock				27,128
2016-03-02		3	SNDX	Syndax Pharmaceuticals Inc Common Stock				27,128
2016-03-02		3	SNDX	Syndax Pharmaceuticals Inc Common Stock				27,128
2016-03-02		3	SNDX	Syndax Pharmaceuticals Inc Common Stock				27,128
2016-03-02		3	SNDX	Syndax Pharmaceuticals Inc Common Stock				27,128
2016-03-02		3	SNDX	Syndax Pharmaceuticals Inc Common Stock				27,128
2016-03-02		3	SNDX	Syndax Pharmaceuticals Inc Common Stock				27,128
2016-03-02		3	SNDX	Syndax Pharmaceuticals Inc Common Stock				27,128
2015-08-20	2015-08-18	4	EVOK	Evoke Pharma Inc Common Stock	S - Sale		-11,836	1,052,328	-1.11	7.02	-83,089	7,387,343
2015-08-20	2015-08-18	4	EVOK	Evoke Pharma Inc Common Stock	S - Sale		-202	17,947	-1.11	7.02	-1,418	125,988
2015-07-01	2015-06-30	4	GKOS	GLAUKOS Corp Series F Preferred Stock	C - Conversion		-286,983	0	-100.00
2015-07-01	2015-06-30	4	GKOS	GLAUKOS Corp Series E Preferred Stock	C - Conversion		-589,100	0	-100.00
2015-07-01	2015-06-30	4	GKOS	GLAUKOS Corp Common Stock	C - Conversion		876,083	876,083
2015-07-01	2015-06-30	4	GKOS	GLAUKOS Corp Series F Preferred Stock	C - Conversion		-2,130	0	-100.00
2015-07-01	2015-06-30	4	GKOS	GLAUKOS Corp Series E Preferred Stock	C - Conversion		-4,371	0	-100.00
2015-07-01	2015-06-30	4	GKOS	GLAUKOS Corp Common Stock	C - Conversion		6,501	6,501
2015-07-01	2015-06-30	4	GKOS	GLAUKOS Corp Warrant	M - Exercise		-20,470	0	-100.00
2015-07-01	2015-06-30	4	GKOS	GLAUKOS Corp Series D Preferred Stock	C - Conversion		-105,128	0	-100.00
2015-07-01	2015-06-30	4	GKOS	GLAUKOS Corp Series C Preferred Stock	C - Conversion		-440,178	0	-100.00
2015-07-01	2015-06-30	4	GKOS	GLAUKOS Corp Series B Preferred Stock	C - Conversion		-925,926	0	-100.00
2015-07-01	2015-06-30	4	GKOS	GLAUKOS Corp Series A Preferred Stock	C - Conversion		-585,958	0	-100.00
2015-07-01	2015-06-30	4	GKOS	GLAUKOS Corp Common Stock	F - Taxes		-8,700	2,068,960	-0.42	18.00	-156,600	37,241,280
2015-07-01	2015-06-30	4	GKOS	GLAUKOS Corp Common Stock	M - Exercise		20,470	2,077,660	1.00	7.65	156,596	15,894,099
2015-07-01	2015-06-30	4	GKOS	GLAUKOS Corp Common Stock	C - Conversion		2,057,190	2,057,190
2015-07-01	2015-06-30	4	GKOS	GLAUKOS Corp Series A Preferred Stock	C - Conversion		-14,041	0	-100.00
2015-07-01	2015-06-30	4	GKOS	GLAUKOS Corp Common Stock	C - Conversion		14,041	14,041
2015-06-24		3	GKOS	GLAUKOS Corp Common Stock				126,400
2015-06-24		3	GKOS	GLAUKOS Corp Common Stock				126,400
2015-06-24		3	GKOS	GLAUKOS Corp Common Stock				126,400
2015-06-24		3	GKOS	GLAUKOS Corp Common Stock				126,400
2015-06-24		3	GKOS	GLAUKOS Corp Common Stock				126,400
2015-06-24		3	GKOS	GLAUKOS Corp Common Stock				126,400
2015-06-24		3	GKOS	GLAUKOS Corp Common Stock				126,400
2015-06-24		3	GKOS	GLAUKOS Corp Common Stock				126,400
2015-06-24		3	GKOS	GLAUKOS Corp Common Stock				126,400
2015-06-10	2015-06-09	4	OREX	Orexigen Therapeutics, Inc. Stock Option (Right to Buy)	A - Award		50,000	50,000
2015-05-29	2015-05-27	4	RVA	REVA Medical, Inc. Common Stock	A - Award		15,000	15,000
2015-05-29	2015-05-28	4	OTIC	Otonomy, Inc. Common Stock	J - Other		32,745	32,745
2015-05-29	2015-05-28	4	OTIC	Otonomy, Inc. Common Stock	J - Other		-250,000	1,329,323	-15.83
2015-05-12	2015-05-12	4	LIFE	aTYR PHARMA INC Series E Preferred Stock	C - Conversion		-887,073	0	-100.00
2015-05-12	2015-05-12	4	LIFE	aTYR PHARMA INC Series D Preferred Stock	C - Conversion		-1,506,901	0	-100.00
2015-05-12	2015-05-12	4	LIFE	aTYR PHARMA INC Series C Preferred Stock	C - Conversion		-12,143,933	0	-100.00
2015-05-12	2015-05-12	4	LIFE	aTYR PHARMA INC Common Stock	C - Conversion		1,807,820	1,807,820
2015-05-12	2015-05-12	4	LIFE	aTYR PHARMA INC Series E Preferred Stock	C - Conversion		-6,581	0	-100.00
2015-05-12	2015-05-12	4	LIFE	aTYR PHARMA INC Series D Preferred Stock	C - Conversion		-11,182	0	-100.00
2015-05-12	2015-05-12	4	LIFE	aTYR PHARMA INC Series C Preferred Stock	C - Conversion		-90,110	0	-100.00
2015-05-12	2015-05-12	4	LIFE	aTYR PHARMA INC Common Stock	C - Conversion		13,414	13,414
2015-05-11	2015-05-11	4	CLCD	CoLucid Pharmaceuticals, Inc. Series B Preferred Stock	C - Conversion		-1,565	0	-100.00
2015-05-11	2015-05-11	4	CLCD	CoLucid Pharmaceuticals, Inc. Series A Preferred Stock	C - Conversion		-1,954	0	-100.00
2015-05-11	2015-05-11	4	CLCD	CoLucid Pharmaceuticals, Inc. Common Stock	C - Conversion		3,519	3,519
2015-05-11	2015-05-11	4	CLCD	CoLucid Pharmaceuticals, Inc. Series C Preferred Stock	C - Conversion		-464,756	0	-100.00
2015-05-11	2015-05-11	4	CLCD	CoLucid Pharmaceuticals, Inc. Series B Preferred Stock	C - Conversion		-939,289	0	-100.00
2015-05-11	2015-05-11	4	CLCD	CoLucid Pharmaceuticals, Inc. Series A Preferred Stock	C - Conversion		-798,188	0	-100.00
2015-05-11	2015-05-11	4	CLCD	CoLucid Pharmaceuticals, Inc. Common Stock	C - Conversion		2,202,233	2,245,902	5,043.01
2015-05-06	2015-05-04	4	TBRA	Tibira Therapeutics, Inc. Common Stock	J - Other		36,187	38,094	1,897.59
2015-05-06	2015-05-04	4	TBRA	Regado Biosciences Inc Common Stock	P - Purchase		277,777	3,553,322	8.48	10.62	2,949,992	37,736,280
2015-05-06		3	TBRA	Regado Biosciences Inc Common Stock				6,551,090
2015-05-06		3	TBRA	Regado Biosciences Inc Common Stock				6,551,090
2015-05-06		3	TBRA	Regado Biosciences Inc Common Stock				6,551,090
2015-05-06		3	TBRA	Regado Biosciences Inc Common Stock				6,551,090
2015-05-06		3	TBRA	Regado Biosciences Inc Common Stock				6,551,090
2015-05-06		3	TBRA	Regado Biosciences Inc Common Stock				6,551,090
2015-05-06		3	TBRA	Regado Biosciences Inc Common Stock				6,551,090
2015-05-06		3	TBRA	Regado Biosciences Inc Common Stock				6,551,090
2015-05-06		3	TBRA	Tibira Therapeutics, Inc. Common Stock				95,226
2015-05-06		3	TBRA	Tibira Therapeutics, Inc. Common Stock				95,226
2015-05-06		3	TBRA	Tibira Therapeutics, Inc. Common Stock				95,226
2015-05-06		3	TBRA	Tibira Therapeutics, Inc. Common Stock				95,226
2015-05-06		3	TBRA	Tibira Therapeutics, Inc. Common Stock				95,226
2015-05-06		3	TBRA	Tibira Therapeutics, Inc. Common Stock				95,226
2015-05-06		3	TBRA	Tibira Therapeutics, Inc. Common Stock				95,226
2015-05-06		3	TBRA	Tibira Therapeutics, Inc. Common Stock				95,226
2015-05-06		3	LIFE	aTYR PHARMA INC Common Stock				18,858
2015-05-06		3	LIFE	aTYR PHARMA INC Common Stock				18,858
2015-05-06		3	LIFE	aTYR PHARMA INC Common Stock				18,858
2015-05-06		3	LIFE	aTYR PHARMA INC Common Stock				18,858
2015-05-06		3	LIFE	aTYR PHARMA INC Common Stock				18,858
2015-05-06		3	LIFE	aTYR PHARMA INC Common Stock				18,858
2015-05-06		3	LIFE	aTYR PHARMA INC Common Stock				18,858
2015-05-06		3	LIFE	aTYR PHARMA INC Common Stock				18,858
2015-05-06		3	LIFE	aTYR PHARMA INC Common Stock				18,858
2015-05-06		3	LIFE	aTYR PHARMA INC Common Stock				18,858
2015-05-06		3	LIFE	aTYR PHARMA INC Common Stock				18,858
2015-05-06		3	LIFE	aTYR PHARMA INC Common Stock				18,858
2015-05-06		3	LIFE	aTYR PHARMA INC Common Stock				18,858
2015-05-06		3	LIFE	aTYR PHARMA INC Common Stock				18,858
2015-05-06		3	LIFE	aTYR PHARMA INC Common Stock				18,858
2015-05-06		3	LIFE	aTYR PHARMA INC Common Stock				18,858
2015-05-06		3	LIFE	aTYR PHARMA INC Common Stock				18,858
2015-05-06		3	LIFE	aTYR PHARMA INC Common Stock				18,858
2015-05-05		3	CLCD	CoLucid Pharmaceuticals, Inc. Common Stock				87,338
2015-05-05		3	CLCD	CoLucid Pharmaceuticals, Inc. Common Stock				87,338
2015-05-05		3	CLCD	CoLucid Pharmaceuticals, Inc. Common Stock				87,338
2015-05-05		3	CLCD	CoLucid Pharmaceuticals, Inc. Common Stock				87,338
2015-05-05		3	CLCD	CoLucid Pharmaceuticals, Inc. Common Stock				87,338
2015-05-05		3	CLCD	CoLucid Pharmaceuticals, Inc. Common Stock				87,338
2015-05-05		3	CLCD	CoLucid Pharmaceuticals, Inc. Common Stock				87,338
2015-04-16	2015-04-16	4	EVOK	Evoke Pharma Inc Common Stock	S - Sale		-32,411	1,064,164	-2.96	7.07	-229,146	7,523,639
2015-04-16	2015-04-15	4	EVOK	Evoke Pharma Inc Common Stock	S - Sale		-7,920	1,096,575	-0.72	7.58	-60,034	8,312,038
2015-04-16	2015-04-14	4	EVOK	Evoke Pharma Inc Common Stock	S - Sale		-9,832	1,104,495	-0.88	7.78	-76,493	8,592,971
2015-04-16	2015-04-16	4	EVOK	Evoke Pharma Inc Common Stock	S - Sale		-554	18,149	-2.96	7.07	-3,917	128,313
2015-04-16	2015-04-15	4	EVOK	Evoke Pharma Inc Common Stock	S - Sale		-135	18,703	-0.72	7.58	-1,023	141,769
2015-04-16	2015-04-14	4	EVOK	Evoke Pharma Inc Common Stock	S - Sale		-168	18,838	-0.88	7.78	-1,307	146,560
2015-03-24	2015-03-20	4	ESPR	Esperion Therapeutics, Inc. Common Stock	J - Other		-350,000	2,216,935	-13.63
2014-12-10	2014-11-25	4/A	NEOT	Neothetics, Inc. Series C Preferred Stock Warrant (Right to Buy)	M - Exercise		-2,827	0	-100.00
2014-12-10	2014-11-25	4/A	NEOT	Neothetics, Inc. Series B-2 Preferred Stock Warrant (Right to Buy)	M - Exercise		-1,570	0	-100.00
2014-12-10	2014-11-25	4/A	NEOT	Neothetics, Inc. Series C Preferred Stock	C - Conversion		-102,282	0	-100.00
2014-12-10	2014-11-25	4/A	NEOT	Neothetics, Inc. Series B-2 Preferred Stock	C - Conversion		-36,913	0	-100.00
2014-12-10	2014-11-25	4/A	NEOT	Neothetics, Inc. Series B Preferred Stock	C - Conversion		-104,247	0	-100.00
2014-12-10	2014-11-25	4/A	NEOT	Neothetics, Inc. Series A Preferred Stock	C - Conversion		-12,578	0	-100.00
2014-12-10	2014-11-25	4/A	NEOT	Neothetics, Inc. Common Stock	F - Taxes		-1,725	48,025	-3.47	14.00	-24,150	672,350
2014-12-10	2014-11-25	4/A	NEOT	Neothetics, Inc. Common Stock	M - Exercise		2,827	49,750	6.02	8.54	24,143	424,865
2014-12-10	2014-11-25	4/A	NEOT	Neothetics, Inc. Common Stock	F - Taxes		-958	46,923	-2.00	14.00	-13,412	656,922
2014-12-10	2014-11-25	4/A	NEOT	Neothetics, Inc. Common Stock	M - Exercise		1,570	47,881	3.39	8.54	13,408	408,904
2014-12-10	2014-11-25	4/A	NEOT	Neothetics, Inc. Common Stock	C - Conversion		46,311	46,311
2014-12-10	2014-11-25	4/A	NEOT	Neothetics, Inc. Series C Preferred Stock Warrant (Right to Buy)	M - Exercise		-165,790	0	-100.00
2014-12-10	2014-11-25	4/A	NEOT	Neothetics, Inc. Series B-2 Preferred Stock Warrant (Right to Buy)	M - Exercise		-92,105	0	-100.00
2014-12-10	2014-11-25	4/A	NEOT	Neothetics, Inc. Series C Preferred Stock	C - Conversion		-7,252,144	0	-100.00
2014-12-10	2014-11-25	4/A	NEOT	Neothetics, Inc. Series B-2 Preferred Stock	C - Conversion		-2,164,305	0	-100.00
2014-12-10	2014-11-25	4/A	NEOT	Neothetics, Inc. Series B Preferred Stock	C - Conversion		-6,111,968	0	-100.00
2014-12-10	2014-11-25	4/A	NEOT	Neothetics, Inc. Series A Preferred Stock	C - Conversion		-737,422	0	-100.00
2014-12-10	2014-11-25	4/A	NEOT	Neothetics, Inc. Common Stock	P - Purchase		70,000	3,091,643	2.32	14.00	980,000	43,283,002
2014-12-10	2014-11-25	4/A	NEOT	Neothetics, Inc. Common Stock	F - Taxes		-101,132	3,021,643	-3.24	14.00	-1,415,848	42,303,002
2014-12-10	2014-11-25	4/A	NEOT	Neothetics, Inc. Common Stock	M - Exercise		165,790	3,122,775	5.61	8.54	1,415,847	26,668,498
2014-12-10	2014-11-25	4/A	NEOT	Neothetics, Inc. Common Stock	F - Taxes		-56,185	2,956,985	-1.86	14.00	-786,590	41,397,790
2014-12-10	2014-11-25	4/A	NEOT	Neothetics, Inc. Common Stock	M - Exercise		92,105	3,013,170	3.15	8.54	786,577	25,732,472
2014-12-10	2014-11-25	4/A	NEOT	Neothetics, Inc. Common Stock	C - Conversion		2,921,065	2,921,065
2014-11-26	2014-11-25	4	NEOT	Neothetics, Inc. Series C Preferred Stock Warrant (Right to Buy)	M - Exercise		-165,790	0	-100.00
2014-11-26	2014-11-25	4	NEOT	Neothetics, Inc. Series B-2 Preferred Stock Warrant (Right to Buy)	M - Exercise		-92,105	0	-100.00
2014-11-26	2014-11-25	4	NEOT	Neothetics, Inc. Series C Preferred Stock	C - Conversion		-7,252,144	0	-100.00
2014-11-26	2014-11-25	4	NEOT	Neothetics, Inc. Series B-2 Preferred Stock	C - Conversion		-2,164,305	0	-100.00
2014-11-26	2014-11-25	4	NEOT	Neothetics, Inc. Series B Preferred Stock	C - Conversion		-6,111,968	0	-100.00
2014-11-26	2014-11-25	4	NEOT	Neothetics, Inc. Series A Preferred Stock	C - Conversion		-737,422	0	-100.00
2014-11-26	2014-11-25	4	NEOT	Neothetics, Inc. Common Stock	P - Purchase		70,000	3,091,642	2.32	14.00	980,000	43,282,988
2014-11-26	2014-11-25	4	NEOT	Neothetics, Inc. Common Stock	F - Taxes		-101,132	3,021,642	-3.24	14.00	-1,415,848	42,302,988
2014-11-26	2014-11-25	4	NEOT	Neothetics, Inc. Common Stock	M - Exercise		165,790	3,122,774	5.61	8.54	1,415,847	26,668,490
2014-11-26	2014-11-25	4	NEOT	Neothetics, Inc. Common Stock	F - Taxes		-56,185	2,956,984	-1.86	14.00	-786,590	41,397,776
2014-11-26	2014-11-25	4	NEOT	Neothetics, Inc. Common Stock	M - Exercise		92,105	3,013,169	3.15	8.54	786,577	25,732,463
2014-11-26	2014-11-25	4	NEOT	Neothetics, Inc. Common Stock	C - Conversion		2,921,064	2,921,064
2014-11-26	2014-11-25	4	NEOT	Neothetics, Inc. Series C Preferred Stock Warrant (Right to Buy)	M - Exercise		-2,827	0	-100.00
2014-11-26	2014-11-25	4	NEOT	Neothetics, Inc. Series B-2 Preferred Stock Warrant (Right to Buy)	M - Exercise		-1,570	0	-100.00
2014-11-26	2014-11-25	4	NEOT	Neothetics, Inc. Series C Preferred Stock	C - Conversion		-102,282	0	-100.00
2014-11-26	2014-11-25	4	NEOT	Neothetics, Inc. Series B-2 Preferred Stock	C - Conversion		-36,913	0	-100.00
2014-11-26	2014-11-25	4	NEOT	Neothetics, Inc. Series B Preferred Stock	C - Conversion		-104,247	0	-100.00
2014-11-26	2014-11-25	4	NEOT	Neothetics, Inc. Series A Preferred Stock	C - Conversion		-12,578	0	-100.00
2014-11-26	2014-11-25	4	NEOT	Neothetics, Inc. Common Stock	F - Taxes		-1,725	48,023	-3.47	14.00	-24,150	672,322
2014-11-26	2014-11-25	4	NEOT	Neothetics, Inc. Common Stock	M - Exercise		2,827	49,748	6.03	8.54	24,143	424,848
2014-11-26	2014-11-25	4	NEOT	Neothetics, Inc. Common Stock	F - Taxes		-958	46,921	-2.00	14.00	-13,412	656,894
2014-11-26	2014-11-25	4	NEOT	Neothetics, Inc. Common Stock	M - Exercise		1,570	47,879	3.39	8.54	13,408	408,887
2014-11-26	2014-11-25	4	NEOT	Neothetics, Inc. Common Stock	C - Conversion		46,309	46,309
2014-11-19		3	NEOT	Neothetics, Inc. Common Stock				7,868
2014-11-19		3	NEOT	Neothetics, Inc. Common Stock				7,868
2014-11-19		3	NEOT	Neothetics, Inc. Common Stock				7,868
2014-11-19		3	NEOT	Neothetics, Inc. Common Stock				7,868
2014-11-19		3	NEOT	Neothetics, Inc. Common Stock				7,868
2014-11-19		3	NEOT	Neothetics, Inc. Common Stock				7,868
2014-11-19		3	NEOT	Neothetics, Inc. Common Stock				7,868
2014-11-19		3	NEOT	Neothetics, Inc. Common Stock				7,868
2014-11-19		3	NEOT	Neothetics, Inc. Common Stock				7,868
2014-11-18	2014-11-17	4	DRTX	Durata Therapeutics, Inc. Common Stock	D - Sale to Issuer		-6,250	0	-100.00
2014-11-18	2014-11-17	4	DRTX	Durata Therapeutics, Inc. Common Stock	D - Sale to Issuer		-22,306	0	-100.00
2014-11-18	2014-11-17	4	DRTX	Durata Therapeutics, Inc. Common Stock	D - Sale to Issuer		-3,006,132	0	-100.00
2014-10-21	2014-10-21	4	ESPR	Esperion Therapeutics, Inc. Common Stock	P - Purchase		500,000	2,566,935	24.19	20.00	10,000,000	51,338,700
2014-10-21	2014-10-21	4	ATRA	Atara Biotherapeutics, Inc. Series B Preferred Stock	C - Conversion		-4,606	0	-100.00
2014-10-21	2014-10-21	4	ATRA	Atara Biotherapeutics, Inc. Series A Preferred Stock	C - Conversion		-9,443	0	-100.00
2014-10-21	2014-10-21	4	ATRA	Atara Biotherapeutics, Inc. Common Stock	P - Purchase		1,841	15,890	13.10	11.00	20,251	174,790
2014-10-21	2014-10-21	4	ATRA	Atara Biotherapeutics, Inc. Common Stock	C - Conversion		14,049	14,049
2014-10-21	2014-10-21	4	ATRA	Atara Biotherapeutics, Inc. Series B Preferred Stock	C - Conversion		-620,776	0	-100.00
2014-10-21	2014-10-21	4	ATRA	Atara Biotherapeutics, Inc. Series A Preferred Stock	C - Conversion		-1,272,607	0	-100.00
2014-10-21	2014-10-21	4	ATRA	Atara Biotherapeutics, Inc. Common Stock	P - Purchase		248,159	2,141,542	13.11	11.00	2,729,749	23,556,962
2014-10-21	2014-10-21	4	ATRA	Atara Biotherapeutics, Inc. Common Stock	C - Conversion		1,893,383	1,893,383
2014-09-12	2014-09-10	4	VCYT	VERACYTE, INC. Common Stock	J - Other		-300,000	2,763,294	-9.79
2014-08-18	2014-08-18	4	OTIC	Otonomy, Inc. Series C Preferred Stock Warrant (Right to Buy)	M - Exercise		-502	0	-100.00
2014-08-18	2014-08-18	4	OTIC	Otonomy, Inc. Series D Preferred Stock	F - Taxes		-1,386	0	-100.00
2014-08-18	2014-08-18	4	OTIC	Otonomy, Inc. Series C Preferred Stock	C - Conversion		-6,866	0	-100.00
2014-08-18	2014-08-18	4	OTIC	Otonomy, Inc. Series B Preferred Stock	C - Conversion		-3,238	0	-100.00
2014-08-18	2014-08-18	4	OTIC	Otonomy, Inc. Common Stock	F - Taxes		-277	11,715	-2.31	16.00	-4,432	187,440
2014-08-18	2014-08-18	4	OTIC	Otonomy, Inc. Common Stock	M - Exercise		502	11,992	4.37	8.79	4,413	105,410
2014-08-18	2014-08-18	4	OTIC	Otonomy, Inc. Common Stock	C - Conversion		11,490	11,490
2014-08-18	2014-08-18	4	OTIC	Otonomy, Inc. Series C Preferred Stock Warrant (Right to Buy)	M - Exercise		-67,755	0	-100.00
2014-08-18	2014-08-18	4	OTIC	Otonomy, Inc. Series D Preferred Stock	F - Taxes		-186,828	0	-100.00
2014-08-18	2014-08-18	4	OTIC	Otonomy, Inc. Series C Preferred Stock	C - Conversion		-925,479	0	-100.00
2014-08-18	2014-08-18	4	OTIC	Otonomy, Inc. Series B Preferred Stock	C - Conversion		-436,485	0	-100.00
2014-08-18	2014-08-18	4	OTIC	Otonomy, Inc. Common Stock	F - Taxes		-37,224	1,579,323	-2.30	16.00	-595,584	25,269,168
2014-08-18	2014-08-18	4	OTIC	Otonomy, Inc. Common Stock	M - Exercise		67,755	1,616,547	4.37	8.79	595,566	14,209,448
2014-08-18	2014-08-18	4	OTIC	Otonomy, Inc. Common Stock	C - Conversion		1,548,792	1,548,792
2014-08-07	2014-08-05	4	MRNS	MARINUS PHARMACEUTICALS INC Series C Preferred Stock	C - Conversion		-1,165	0	-100.00
2014-08-07	2014-08-05	4	MRNS	MARINUS PHARMACEUTICALS INC Series B Preferred Stock	C - Conversion		-7,043	0	-100.00
2014-08-07	2014-08-05	4	MRNS	MARINUS PHARMACEUTICALS INC Series A Preferred Stock	C - Conversion		-8,792	0	-100.00
2014-08-07	2014-08-05	4	MRNS	MARINUS PHARMACEUTICALS INC Common Stock	C - Conversion		17,000	17,000
2014-08-07	2014-08-05	4	MRNS	MARINUS PHARMACEUTICALS INC Series C Preferred Stock	C - Conversion		-579,630	0	-100.00
2014-08-07	2014-08-05	4	MRNS	MARINUS PHARMACEUTICALS INC Series B Preferred Stock	C - Conversion		-657,192	0	-100.00
2014-08-07	2014-08-05	4	MRNS	MARINUS PHARMACEUTICALS INC Series A Preferred Stock	C - Conversion		-820,320	0	-100.00
2014-08-07	2014-08-05	4	MRNS	MARINUS PHARMACEUTICALS INC Common Stock	P - Purchase		419,744	2,476,886	20.40	8.00	3,357,952	19,815,088
2014-08-07	2014-08-05	4	MRNS	MARINUS PHARMACEUTICALS INC Common Stock	C - Conversion		2,057,142	2,057,142
2014-07-31		3	MRNS	MARINUS PHARMACEUTICALS INC Common Stock				85,100
2014-07-31		3	MRNS	MARINUS PHARMACEUTICALS INC Common Stock				85,100
2014-07-31		3	MRNS	MARINUS PHARMACEUTICALS INC Common Stock				85,100
2014-07-31		3	MRNS	MARINUS PHARMACEUTICALS INC Common Stock				85,100
2014-07-31		3	MRNS	MARINUS PHARMACEUTICALS INC Common Stock				85,100
2014-07-31		3	MRNS	MARINUS PHARMACEUTICALS INC Common Stock				85,100
2014-07-31		3	MRNS	MARINUS PHARMACEUTICALS INC Common Stock				85,100
2014-07-31		3	MRNS	MARINUS PHARMACEUTICALS INC Common Stock				85,100
2014-07-31		3	MRNS	MARINUS PHARMACEUTICALS INC Common Stock				85,100
2014-06-30	2014-06-27	4	OREX	Orexigen Therapeutics, Inc. Stock Option (Right to Buy)	A - Award		50,000	50,000
2014-05-14	2014-05-12	4	RVA	REVA Medical, Inc. Stock Option (Right to Buy)	A - Award		15,000	15,000
2014-05-07	2014-05-07	4	ALDX	Aldeyra Therapeutics, Inc. Convertible Promissory Note	C - Conversion			0
2014-05-07	2014-05-07	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	C - Conversion		21,250	1,973,389	1.09
2014-05-05	2014-05-01	4	ALDX	Aldeyra Therapeutics, Inc. Series A Preferred Stock	C - Conversion		-3,882	0	-100.00
2014-05-05	2014-05-01	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	C - Conversion		9,208	9,208
2014-05-05	2014-05-01	4	ALDX	Aldeyra Therapeutics, Inc. Series B Preferred Stock Warrant (Right to Buy)	M - Exercise		-60,576	0	-100.00
2014-05-05	2014-05-01	4	ALDX	Aldeyra Therapeutics, Inc. Series B Preferred Stock Warrant (Right to Buy)	M - Exercise		-60,576	0	-100.00
2014-05-05	2014-05-01	4	ALDX	Aldeyra Therapeutics, Inc. Series B Preferred Stock	C - Conversion		-755,263	0	-100.00
2014-05-05	2014-05-01	4	ALDX	Aldeyra Therapeutics, Inc. Series A Preferred Stock	C - Conversion		-486,316	0	-100.00
2014-05-05	2014-05-01	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	F - Taxes		-39,063	1,952,139	-1.96	8.00	-312,504	15,617,112
2014-05-05	2014-05-01	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	F - Taxes		-39,063	1,952,139	-1.96	8.00	-312,504	15,617,112
2014-05-05	2014-05-01	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	M - Exercise		60,576	1,991,202	3.14	5.16	312,572	10,274,602
2014-05-05	2014-05-01	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	M - Exercise		60,576	1,991,202	3.14	5.16	312,572	10,274,602
2014-05-05	2014-05-01	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	C - Conversion		1,909,113	1,909,113
2014-05-01		3	ALDX	Aldeyra Therapeutics, Inc. Common Stock				20,716
2014-05-01		3	ALDX	Aldeyra Therapeutics, Inc. Common Stock				20,716
2014-05-01		3	ALDX	Aldeyra Therapeutics, Inc. Common Stock				20,716
2014-05-01		3	ALDX	Aldeyra Therapeutics, Inc. Common Stock				20,716
2014-05-01		3	ALDX	Aldeyra Therapeutics, Inc. Common Stock				20,716
2014-05-01		3	ALDX	Aldeyra Therapeutics, Inc. Common Stock				20,716
2014-05-01		3	ALDX	Aldeyra Therapeutics, Inc. Common Stock				20,716
2014-05-01		3	ALDX	Aldeyra Therapeutics, Inc. Common Stock				20,716
2014-05-01		3	ALDX	Aldeyra Therapeutics, Inc. Common Stock				20,716
2014-04-23	2014-04-22	4	OREX	Orexigen Therapeutics, Inc. Warrant to Purchase Common Stock	M - Exercise		-7,882	0	-100.00
2014-04-23	2014-04-22	4	OREX	Orexigen Therapeutics, Inc. Warrant to Purchase Common Stock	M - Exercise		-461,265	0	-100.00
2014-04-23	2014-04-22	4	OREX	Orexigen Therapeutics, Inc. Common Stock	F - Taxes		-15	129,448	-0.01	5.30	-80	686,074
2014-04-23	2014-04-22	4	OREX	Orexigen Therapeutics, Inc. Common Stock	M - Exercise		78,820	129,463	155.64	0.00	79	129
2014-04-23	2014-04-22	4	OREX	Orexigen Therapeutics, Inc. Common Stock	F - Taxes		-871	7,579,194	-0.01	5.30	-4,616	40,169,728
2014-04-23	2014-04-22	4	OREX	Orexigen Therapeutics, Inc. Common Stock	M - Exercise		4,612,650	7,580,065	155.44	0.00	4,613	7,580
2014-03-21	2014-03-19	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	D - Sale to Issuer		-27,500	0	-100.00	14.00	-385,000
2014-03-21	2014-03-19	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	D - Sale to Issuer		-78,369	0	-100.00	14.00	-1,097,166
2014-03-21	2014-03-19	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	D - Sale to Issuer		-7,313,241	0	-100.00	14.00	-102,385,374
2014-03-21	2014-03-19	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	D - Sale to Issuer		-50,743	0	-100.00	14.00	-710,402
2014-03-21	2014-03-19	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	D - Sale to Issuer		-2,972,678	0	-100.00	14.00	-41,617,492
2014-03-17	2014-03-17	4	AKAO	Achaogen Inc Series D Preferred Stock	C - Conversion		-7,430	0	-100.00
2014-03-17	2014-03-17	4	AKAO	Achaogen Inc Series C Preferred Stock	C - Conversion		-15,799	0	-100.00
2014-03-17	2014-03-17	4	AKAO	Achaogen Inc Series B Preferred Stock	C - Conversion		-10,661	0	-100.00
2014-03-17	2014-03-17	4	AKAO	Achaogen Inc Series D Preferred Stock	C - Conversion		-435,663	0	-100.00
2014-03-17	2014-03-17	4	AKAO	Achaogen Inc Series C Preferred Stock	C - Conversion		-926,321	0	-100.00
2014-03-17	2014-03-17	4	AKAO	Achaogen Inc Series B Preferred Stock	C - Conversion		-625,065	0	-100.00
2014-03-17	2014-03-17	4	AKAO	Achaogen Inc Common Stock	C - Conversion		33,890	33,890
2014-03-17	2014-03-17	4	AKAO	Achaogen Inc Common Stock	C - Conversion		1,987,049	1,987,049
2014-02-14	2014-02-12	4	CADX	CADENCE PHARMACEUTICALS INC Warrants to Purchase Common Stock	M - Exercise		-1,367,020	0	-100.00
2014-02-14	2014-02-12	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	F - Taxes		-765,532	2,972,678	-20.48	14.00	-10,717,448	41,617,492
2014-02-14	2014-02-12	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	M - Exercise		1,367,020	3,738,210	57.65	7.84	10,717,437	29,307,566
2014-02-14	2014-02-12	4	CADX	CADENCE PHARMACEUTICALS INC Warrants to Purchase Common Stock	M - Exercise		-23,317	0	-100.00
2014-02-14	2014-02-12	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	F - Taxes		-13,058	50,743	-20.47	14.00	-182,812	710,402
2014-02-14	2014-02-12	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	M - Exercise		23,317	63,801	57.60	7.84	182,805	500,200
2014-02-04	2014-02-04	4	DRNA	Dicerna Pharmaceuticals Inc Warrant	C - Conversion		156	156
2014-02-04	2014-02-04	4	DRNA	Dicerna Pharmaceuticals Inc Warrant	C - Conversion		-156	0	-100.00
2014-02-04	2014-02-04	4	DRNA	Dicerna Pharmaceuticals Inc Series C Preferred Stock	C - Conversion		-9,469	0	-100.00
2014-02-04	2014-02-04	4	DRNA	Dicerna Pharmaceuticals Inc Series B Preferred Stock	C - Conversion		-3,535	0	-100.00
2014-02-04	2014-02-04	4	DRNA	Dicerna Pharmaceuticals Inc Warrant	C - Conversion		21,041	21,041
2014-02-04	2014-02-04	4	DRNA	Dicerna Pharmaceuticals Inc Warrant	C - Conversion		-21,041	0	-100.00
2014-02-04	2014-02-04	4	DRNA	Dicerna Pharmaceuticals Inc Series C Preferred Stock	C - Conversion		-1,276,243	0	-100.00
2014-02-04	2014-02-04	4	DRNA	Dicerna Pharmaceuticals Inc Series B Preferred Stock	C - Conversion		-476,464	0	-100.00
2014-02-04	2014-02-04	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	C - Conversion		13,004	13,004
2014-02-04	2014-02-04	4	DRNA	Dicerna Pharmaceuticals Inc Common Stock	C - Conversion		1,752,707	1,752,707
2014-01-17	2014-01-16	4	ALIM	ALIMERA SCIENCES INC Common Stock	S - Sale	X	-2,230	34,907	-6.00	6.56	-14,629	228,990
2014-01-17	2014-01-15	4	ALIM	ALIMERA SCIENCES INC Common Stock	S - Sale	X	-1,010	37,137	-2.65	6.01	-6,070	223,193
2014-01-17	2014-01-16	4	ALIM	ALIMERA SCIENCES INC Common Stock	S - Sale	X	-204,315	3,590,931	-5.38	6.56	-1,340,306	23,556,507
2014-01-17	2014-01-15	4	ALIM	ALIMERA SCIENCES INC Common Stock	S - Sale	X	-92,445	3,795,246	-2.38	6.01	-555,594	22,809,428
2013-11-19	2013-11-19	4	TNDM	TANDEM DIABETES CARE INC Warrant to Purchase Common Stock	J - Other		6,008	6,008
2013-11-19	2013-11-19	4	TNDM	TANDEM DIABETES CARE INC Warrant to Purchase Series D Preferred Stock	J - Other		-10,068	0	-100.00
2013-11-19	2013-11-19	4	TNDM	TANDEM DIABETES CARE INC Series D Preferred Stock	C - Conversion		-38,941	0	-100.00
2013-11-19	2013-11-19	4	TNDM	TANDEM DIABETES CARE INC Series C Preferred Stock	C - Conversion		-9,378	0	-100.00
2013-11-19	2013-11-19	4	TNDM	TANDEM DIABETES CARE INC Series B Preferred Stock	C - Conversion		-6,071	0	-100.00
2013-11-19	2013-11-19	4	TNDM	TANDEM DIABETES CARE INC Warrant to Purchase Common Stock	J - Other		352,351	352,351
2013-11-19	2013-11-19	4	TNDM	TANDEM DIABETES CARE INC Warrant to Purchase Series D Preferred Stock	J - Other		-590,403	0	-100.00
2013-11-19	2013-11-19	4	TNDM	TANDEM DIABETES CARE INC Series D Preferred Stock	C - Conversion		-2,283,114	0	-100.00
2013-11-19	2013-11-19	4	TNDM	TANDEM DIABETES CARE INC Series C Preferred Stock	C - Conversion		-549,833	0	-100.00
2013-11-19	2013-11-19	4	TNDM	TANDEM DIABETES CARE INC Series B Preferred Stock	C - Conversion		-356,111	0	-100.00
2013-11-19	2013-11-19	4	TNDM	TANDEM DIABETES CARE INC Common Stock	C - Conversion		54,390	54,390
2013-11-19	2013-11-19	4	TNDM	TANDEM DIABETES CARE INC Common Stock	C - Conversion		3,189,058	3,189,058
2013-11-04	2013-11-04	4	VCYT	VERACYTE, INC. Series C Preferred Stock	C - Conversion		-5,053	0	-100.00
2013-11-04	2013-11-04	4	VCYT	VERACYTE, INC. Series C Preferred Stock	C - Conversion		-680,972	0	-100.00
2013-11-04	2013-11-04	4	VCYT	VERACYTE, INC. Series B Preferred Stock	C - Conversion		-17,677	0	-100.00
2013-11-04	2013-11-04	4	VCYT	VERACYTE, INC. Series B Preferred Stock	C - Conversion		-2,382,322	0	-100.00
2013-11-04	2013-11-04	4	VCYT	VERACYTE, INC. Common Stock	C - Conversion		22,730	22,730
2013-11-04	2013-11-04	4	VCYT	VERACYTE, INC. Common Stock	C - Conversion		3,063,294	3,063,294
2013-09-30	2013-09-30	4	EVOK	Evoke Pharma Inc Series A Preferred Stock	C - Conversion		-19,006	0	-100.00
2013-09-30	2013-09-30	4	EVOK	Evoke Pharma Inc Series A Preferred Stock	C - Conversion		-1,114,327	0	-100.00
2013-09-30	2013-09-30	4	EVOK	Evoke Pharma Inc Common Stock	C - Conversion		19,006	19,006
2013-09-30	2013-09-30	4	EVOK	Evoke Pharma Inc Common Stock	C - Conversion		1,114,327	1,114,327
2013-09-24		3	EVOK	Evoke Pharma Inc Common Stock				5,250
2013-08-28	2013-08-27	4	RGDO	Regado Biosciences Inc Series D Preferred Stock	C - Conversion		-7,407	0	-100.00
2013-08-28	2013-08-27	4	RGDO	Regado Biosciences Inc Series C Preferred Stock	C - Conversion		-2,899	0	-100.00
2013-08-28	2013-08-27	4	RGDO	Regado Biosciences Inc Series B Preferred Stock	C - Conversion		-4,233	0	-100.00
2013-08-28	2013-08-27	4	RGDO	Regado Biosciences Inc Series E Preferred Stock	C - Conversion		-225,913	0	-100.00
2013-08-28	2013-08-27	4	RGDO	Regado Biosciences Inc Series D Preferred Stock	C - Conversion		-894,120	0	-100.00
2013-08-28	2013-08-27	4	RGDO	Regado Biosciences Inc Series C Preferred Stock	C - Conversion		-270,568	0	-100.00
2013-08-28	2013-08-27	4	RGDO	Regado Biosciences Inc Series B Preferred Stock	C - Conversion		-394,969	0	-100.00
2013-08-28	2013-08-27	4	RGDO	Regado Biosciences Inc Common Stock	C - Conversion		7,407	14,920	98.59
2013-08-28	2013-08-27	4	RGDO	Regado Biosciences Inc Common Stock	C - Conversion		2,899	7,513	62.83
2013-08-28	2013-08-27	4	RGDO	Regado Biosciences Inc Common Stock	C - Conversion		4,233	4,614	1,111.02
2013-08-28	2013-08-27	4	RGDO	Regado Biosciences Inc Common Stock	P - Purchase		750,000	2,571,117	41.18	4.00	3,000,000	10,284,468
2013-08-28	2013-08-27	4	RGDO	Regado Biosciences Inc Common Stock	C - Conversion		225,913	1,821,117	14.16
2013-08-28	2013-08-27	4	RGDO	Regado Biosciences Inc Common Stock	C - Conversion		894,120	1,595,204	127.53
2013-08-28	2013-08-27	4	RGDO	Regado Biosciences Inc Common Stock	C - Conversion		270,568	701,084	62.85
2013-08-28	2013-08-27	4	RGDO	Regado Biosciences Inc Common Stock	C - Conversion		394,969	430,516	1,111.12
2013-08-21		3	RGDO	Regado Biosciences Inc Common Stock				35,547
2013-08-21		3	RGDO	Regado Biosciences Inc Common Stock				381
2013-08-21		3	RGDO	Regado Biosciences Inc Common Stock				17,171
2013-07-31	2013-07-15	4/A	OCRX	Ocera Therapeutics, Inc. Common Stock	P - Purchase		331,873	1,857,036	21.76	6.03	1,999,999	11,191,242
2013-07-31	2013-07-15	4/A	OCRX	Ocera Therapeutics, Inc. Common Stock	P - Purchase		7,333	7,333		6.03	44,192	44,192
2013-07-31	2013-07-15	4/A	OCRX	Ocera Therapeutics, Inc. Common Stock	P - Purchase		988,285	988,285		6.03	5,955,801	5,955,801
2013-07-31		3/A	OCRX	Ocera Therapeutics, Inc. Common Stock				47,963
2013-07-31		3/A	OCRX	Ocera Therapeutics, Inc. Common Stock				1,525,163
2013-07-31		3/A	OCRX	Ocera Therapeutics, Inc. Common Stock				15,731
2013-07-16	2013-07-15	4	OCRX	Ocera Therapeutics, Inc. Common Stock	P - Purchase		331,873	1,897,336	21.20	6.03	1,999,999	11,434,106
2013-07-16	2013-07-15	4	OCRX	Ocera Therapeutics, Inc. Common Stock	P - Purchase		7,333	7,333		6.03	44,192	44,192
2013-07-16	2013-07-15	4	OCRX	Ocera Therapeutics, Inc. Common Stock	P - Purchase		988,285	988,285		6.03	5,955,801	5,955,801
2013-07-16		3	OCRX	Ocera Therapeutics, Inc. Common Stock				47,963
2013-07-16		3	OCRX	Ocera Therapeutics, Inc. Common Stock				1,565,463
2013-07-16		3	OCRX	Ocera Therapeutics, Inc. Common Stock				15,731
2013-07-02	2013-07-01	4	ESPR	Esperion Therapeutics, Inc. Warrant to Purchase Common Stock	J - Other		1,193	1,193
2013-07-02	2013-07-01	4	ESPR	Esperion Therapeutics, Inc. Warrant to Purchase Series A Preferred Stock	J - Other		-8,346	0	-100.00
2013-07-02	2013-07-01	4	ESPR	Esperion Therapeutics, Inc. Series A Preferred Stock	C - Conversion		-30,462	0	-100.00
2013-07-02	2013-07-01	4	ESPR	Esperion Therapeutics, Inc. Warrant to Purchase Common Stock	J - Other		70,042	70,042
2013-07-02	2013-07-01	4	ESPR	Esperion Therapeutics, Inc. Warrant to Purchase Series A Preferred Stock	J - Other		-489,320	0	-100.00
2013-07-02	2013-07-01	4	ESPR	Esperion Therapeutics, Inc. Series A Preferred Stock	C - Conversion		-1,786,012	0	-100.00
2013-07-02	2013-07-01	4	ESPR	Esperion Therapeutics, Inc. Common Stock	P - Purchase		4,791	35,253	15.73	14.00	67,074	493,542
2013-07-02	2013-07-01	4	ESPR	Esperion Therapeutics, Inc. Common Stock	C - Conversion		30,462	30,462
2013-07-02	2013-07-01	4	ESPR	Esperion Therapeutics, Inc. Common Stock	P - Purchase		280,923	2,066,935	15.73	14.00	3,932,922	28,937,090
2013-07-02	2013-07-01	4	ESPR	Esperion Therapeutics, Inc. Common Stock	C - Conversion		1,786,012	1,786,012
2013-06-25		3	ESPR	Esperion Therapeutics, Inc. Common Stock				21,471
2013-06-24	2013-06-20	4	ALIM	ALIMERA SCIENCES INC Common Stock	S - Sale	X	-114	38,147	-0.30	5.01	-571	191,116
2013-06-24	2013-06-20	4	ALIM	ALIMERA SCIENCES INC Common Stock	S - Sale	X	-10,516	3,887,691	-0.27	5.01	-52,685	19,477,332
2013-06-20	2013-06-19	4	ALIM	ALIMERA SCIENCES INC Common Stock	S - Sale	X	-22,423	3,898,207	-0.57	5.37	-120,412	20,933,372
2013-06-20	2013-06-18	4	ALIM	ALIMERA SCIENCES INC Common Stock	S - Sale	X	-32,855	3,920,630	-0.83	5.40	-177,417	21,171,402
2013-06-20	2013-06-19	4	ALIM	ALIMERA SCIENCES INC Common Stock	S - Sale	X	-244	38,261	-0.63	5.37	-1,310	205,462
2013-06-20	2013-06-18	4	ALIM	ALIMERA SCIENCES INC Common Stock	S - Sale	X	-359	38,505	-0.92	5.40	-1,939	207,927
2013-06-18	2013-06-17	4	ALIM	ALIMERA SCIENCES INC Common Stock	S - Sale	X	-959	38,864	-2.41	5.40	-5,179	209,866
2013-06-18	2013-06-14	4	ALIM	ALIMERA SCIENCES INC Common Stock	S - Sale	X	-425	39,823	-1.06	5.03	-2,138	200,310
2013-06-18	2013-06-17	4	ALIM	ALIMERA SCIENCES INC Common Stock	S - Sale	X	-87,812	3,953,485	-2.17	5.40	-474,185	21,348,819
2013-06-18	2013-06-14	4	ALIM	ALIMERA SCIENCES INC Common Stock	S - Sale	X	-38,897	4,041,297	-0.95	5.03	-195,652	20,327,724
2013-06-13	2013-06-11	4	ALIM	ALIMERA SCIENCES INC Common Stock	S - Sale	X	-59	40,248	-0.15	5.00	-295	201,240
2013-06-13	2013-06-11	4	ALIM	ALIMERA SCIENCES INC Common Stock	S - Sale	X	-5,337	4,080,194	-0.13	5.00	-26,685	20,400,970
2013-06-06	2013-06-05	4	OREX	Orexigen Therapeutics, Inc. Stock Option (Right to Buy)	A - Award		35,000	35,000
2013-06-05	2013-06-04	4	CLVS	Clovis Oncology, Inc. Common Stock	S - Sale		-159,192	2,581,745	-5.81	64.58	-10,280,619	166,729,092
2013-06-05	2013-06-04	4	CLVS	Clovis Oncology, Inc. Common Stock	S - Sale		-2,779	44,034	-5.94	64.58	-179,468	2,843,716
2013-05-31	2013-05-29	4	RVA	REVA Medical, Inc. Stock Option (Right to Buy)	A - Award		15,000	15,000
2013-05-17	2013-05-16	4	ALIM	ALIMERA SCIENCES INC Common Stock	S - Sale		-232	40,307	-0.57	4.50	-1,044	181,382
2013-05-17	2013-05-15	4	ALIM	ALIMERA SCIENCES INC Common Stock	S - Sale		-251	40,539	-0.62	4.70	-1,180	190,533
2013-05-17	2013-05-16	4	ALIM	ALIMERA SCIENCES INC Common Stock	S - Sale		-21,276	4,085,531	-0.52	4.50	-95,742	18,384,890
2013-05-17	2013-05-15	4	ALIM	ALIMERA SCIENCES INC Common Stock	S - Sale		-22,966	4,106,807	-0.56	4.70	-107,940	19,301,993
2013-04-17	2013-04-15	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-23,210	2,371,190	-0.97	6.62	-153,650	15,697,278
2013-04-17	2013-04-15	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-71,578	7,313,241	-0.97	6.62	-473,846	48,413,655
2013-04-10	2013-04-10	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-1,567	2,394,400	-0.07	6.72	-10,530	16,090,368
2013-04-10	2013-04-09	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-11,386	2,395,967	-0.47	6.71	-76,400	16,076,939
2013-04-10	2013-04-08	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-12,217	2,407,353	-0.50	6.52	-79,655	15,695,942
2013-04-10	2013-04-10	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-4,832	7,384,819	-0.07	6.72	-32,471	49,625,984
2013-04-10	2013-04-09	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-35,114	7,389,651	-0.47	6.71	-235,615	49,584,558
2013-04-10	2013-04-08	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-37,676	7,424,765	-0.50	6.52	-245,648	48,409,468
2013-03-22	2013-03-21	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-4,374	2,419,570	-0.18	5.35	-23,401	12,944,700
2013-03-22	2013-03-21	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-893	40,484	-2.16	5.49	-4,903	222,257
2013-03-22	2013-03-21	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-13,490	7,462,441	-0.18	5.35	-72,172	39,924,059
2013-03-22	2013-03-21	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-1,743	78,369	-2.18	5.49	-9,569	430,246
2013-03-21	2013-03-20	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-5,510	2,423,944	-0.23	5.22	-28,762	12,652,988
2013-03-21	2013-03-19	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-7,925	2,429,454	-0.33	5.19	-41,131	12,608,866
2013-03-21	2013-03-20	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-92	41,377	-0.22	5.22	-480	215,988
2013-03-21	2013-03-19	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-134	41,469	-0.32	5.19	-695	215,224
2013-03-21	2013-03-20	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-182	80,112	-0.23	5.22	-950	418,185
2013-03-21	2013-03-19	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-261	80,294	-0.32	5.19	-1,355	416,726
2013-03-21	2013-03-20	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-16,995	7,475,931	-0.23	5.22	-88,714	39,024,360
2013-03-21	2013-03-19	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-24,442	7,492,926	-0.33	5.19	-126,854	38,888,286
2013-03-19	2013-03-18	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-8,020	2,437,379	-0.33	5.16	-41,383	12,576,876
2013-03-19	2013-03-15	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-9,636	2,445,399	-0.39	5.28	-50,878	12,911,707
2013-03-19	2013-03-18	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-135	41,603	-0.32	5.16	-697	214,671
2013-03-19	2013-03-15	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-163	41,738	-0.39	5.28	-861	220,377
2013-03-19	2013-03-18	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-265	80,555	-0.33	5.16	-1,367	415,664
2013-03-19	2013-03-15	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-318	80,820	-0.39	5.28	-1,679	426,730
2013-03-19	2013-03-18	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-24,736	7,517,368	-0.33	5.16	-127,638	38,789,619
2013-03-19	2013-03-15	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-29,719	7,542,104	-0.39	5.28	-156,916	39,822,309
2013-03-15	2013-03-14	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-5,020	2,455,035	-0.20	5.36	-26,907	13,158,988
2013-03-15	2013-03-13	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-7,733	2,460,055	-0.31	5.40	-41,758	13,284,297
2013-03-15	2013-03-14	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-85	41,901	-0.20	5.36	-456	224,589
2013-03-15	2013-03-13	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-131	41,986	-0.31	5.40	-707	226,724
2013-03-15	2013-03-14	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-166	81,138	-0.20	5.36	-890	434,900
2013-03-15	2013-03-13	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-256	81,304	-0.31	5.40	-1,382	439,042
2013-03-15	2013-03-14	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-15,480	7,571,823	-0.20	5.36	-82,973	40,584,971
2013-03-15	2013-03-13	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-23,848	7,587,303	-0.31	5.40	-128,779	40,971,436
2013-03-13	2013-03-12	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-6,346	2,467,788	-0.26	5.38	-34,141	13,276,699
2013-03-13	2013-03-11	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-4,118	2,474,134	-0.17	5.34	-21,990	13,211,876
2013-03-13	2013-03-12	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-107	42,117	-0.25	5.38	-576	226,589
2013-03-13	2013-03-11	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-70	42,224	-0.17	5.34	-374	225,476
2013-03-13	2013-03-12	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-210	81,560	-0.26	5.38	-1,130	438,793
2013-03-13	2013-03-11	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-136	81,770	-0.17	5.34	-726	436,652
2013-03-13	2013-03-12	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-19,569	7,611,151	-0.26	5.38	-105,281	40,947,992
2013-03-13	2013-03-11	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-12,700	7,630,720	-0.17	5.34	-67,818	40,748,045
2013-03-11	2013-03-08	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-5,154	2,478,252	-0.21	5.32	-27,419	13,184,301
2013-03-11	2013-03-07	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-12,701	2,483,406	-0.51	5.22	-66,299	12,963,379
2013-03-11	2013-03-08	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-88	42,294	-0.21	5.32	-468	225,004
2013-03-11	2013-03-07	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-215	42,382	-0.50	5.22	-1,122	221,234
2013-03-11	2013-03-08	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-171	81,906	-0.21	5.32	-910	435,740
2013-03-11	2013-03-07	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-420	82,077	-0.51	5.22	-2,192	428,442
2013-03-11	2013-03-08	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-15,892	7,643,420	-0.21	5.32	-84,545	40,662,994
2013-03-11	2013-03-07	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-39,168	7,659,312	-0.51	5.22	-204,457	39,981,609
2013-03-07	2013-03-06	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-3,839	2,496,107	-0.15	5.06	-19,425	12,630,301
2013-03-07	2013-03-05	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-4,039	2,499,946	-0.16	5.01	-20,235	12,524,729
2013-03-07	2013-03-06	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-65	42,597	-0.15	5.06	-329	215,541
2013-03-07	2013-03-05	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-69	42,662	-0.16	5.01	-346	213,737
2013-03-07	2013-03-06	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-11,841	7,698,480	-0.15	5.06	-59,915	38,954,309
2013-03-07	2013-03-05	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-12,454	7,710,321	-0.16	5.01	-62,395	38,628,708
2013-03-07	2013-03-06	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-127	82,497	-0.15	5.06	-643	417,435
2013-03-07	2013-03-05	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-134	82,624	-0.16	5.01	-671	413,946
2013-03-06	2013-03-06	4	CLVS	Clovis Oncology, Inc. Common Stock	S - Sale		-1,651	46,813	-3.41	24.51	-40,466	1,147,387
2013-03-06	2013-03-05	4	CLVS	Clovis Oncology, Inc. Common Stock	S - Sale		-2,132	48,464	-4.21	24.69	-52,639	1,196,576
2013-03-06	2013-03-04	4	CLVS	Clovis Oncology, Inc. Common Stock	S - Sale		-417	50,596	-0.82	24.44	-10,191	1,236,566
2013-03-06	2013-03-06	4	CLVS	Clovis Oncology, Inc. Common Stock	S - Sale		-98,349	2,740,937	-3.46	24.51	-2,410,534	67,180,366
2013-03-06	2013-03-05	4	CLVS	Clovis Oncology, Inc. Common Stock	S - Sale		-126,868	2,839,286	-4.28	24.69	-3,132,371	70,101,971
2013-03-06	2013-03-04	4	CLVS	Clovis Oncology, Inc. Common Stock	S - Sale		-24,783	2,966,154	-0.83	24.44	-605,697	72,492,804
2013-03-05	2013-03-04	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-5,145	2,503,985	-0.21	5.01	-25,776	12,544,965
2013-03-05	2013-03-01	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-7,635	2,509,130	-0.30	5.01	-38,251	12,570,741
2013-03-05	2013-03-04	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-88	42,731	-0.21	5.01	-441	214,082
2013-03-05	2013-03-01	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-130	42,819	-0.30	5.01	-651	214,523
2013-03-05	2013-03-04	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-170	82,758	-0.20	5.01	-852	414,618
2013-03-05	2013-03-01	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-253	82,928	-0.30	5.01	-1,268	415,469
2013-03-05	2013-03-04	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-15,865	7,722,775	-0.21	5.01	-79,484	38,691,103
2013-03-05	2013-03-01	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-23,548	7,738,640	-0.30	5.01	-117,975	38,770,586
2013-02-22	2013-02-20	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-1,998	2,516,765	-0.08	5.01	-10,010	12,608,993
2013-02-22	2013-02-20	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-34	42,949	-0.08	5.01	-170	215,174
2013-02-22	2013-02-20	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-6,160	7,762,188	-0.08	5.01	-30,862	38,888,562
2013-02-22	2013-02-20	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-66	83,181	-0.08	5.01	-331	416,737
2013-02-20	2013-02-19	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-10,076	2,518,763	-0.40	5.02	-50,582	12,644,190
2013-02-20	2013-02-15	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-2,967	2,528,839	-0.12	5.00	-14,835	12,644,195
2013-02-20	2013-02-19	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-171	42,983	-0.40	5.02	-858	215,775
2013-02-20	2013-02-15	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-51	43,154	-0.12	5.00	-255	215,770
2013-02-20	2013-02-19	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-334	83,247	-0.40	5.02	-1,677	417,900
2013-02-20	2013-02-15	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-99	83,581	-0.12	5.00	-495	417,905
2013-02-20	2013-02-19	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-31,075	7,768,348	-0.40	5.02	-155,996	38,997,107
2013-02-20	2013-02-15	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-9,148	7,799,423	-0.12	5.00	-45,740	38,997,115
2013-02-15	2013-02-14	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-2,951	2,531,806	-0.12	5.01	-14,785	12,684,348
2013-02-15	2013-02-13	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-5,763	2,534,757	-0.23	5.00	-28,815	12,673,785
2013-02-15	2013-02-14	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-51	43,205	-0.12	5.01	-256	216,457
2013-02-15	2013-02-13	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-98	43,256	-0.23	5.00	-490	216,280
2013-02-15	2013-02-14	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-98	83,680	-0.12	5.01	-491	419,237
2013-02-15	2013-02-13	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-191	83,778	-0.23	5.00	-955	418,890
2013-02-15	2013-02-14	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-9,100	7,808,571	-0.12	5.01	-45,591	39,120,941
2013-02-15	2013-02-13	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-17,770	7,817,671	-0.23	5.00	-88,850	39,088,355
2013-02-05	2013-02-01	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-9,769	2,540,520	-0.38	4.85	-47,380	12,321,522
2013-02-05	2013-02-01	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-164	43,354	-0.38	4.85	-795	210,267
2013-02-05	2013-02-01	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-30,134	7,835,441	-0.38	4.85	-146,150	38,001,889
2013-02-05	2013-02-01	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-322	83,969	-0.38	4.85	-1,562	407,250
2013-02-01	2013-01-31	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-18,537	2,550,289	-0.72	4.71	-87,309	12,011,861
2013-02-01	2013-01-30	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-11,105	2,568,826	-0.43	5.00	-55,525	12,844,130
2013-02-01	2013-01-31	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-314	43,518	-0.72	4.71	-1,479	204,970
2013-02-01	2013-01-30	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-188	43,832	-0.43	5.00	-940	219,160
2013-02-01	2013-01-31	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-57,165	7,865,575	-0.72	4.71	-269,247	37,046,858
2013-02-01	2013-01-30	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-34,248	7,922,740	-0.43	5.00	-171,240	39,613,700
2013-02-01	2013-01-31	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-613	84,291	-0.72	4.71	-2,887	397,011
2013-02-01	2013-01-30	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-367	84,904	-0.43	5.00	-1,835	424,520
2013-01-30	2013-01-29	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-15,320	2,579,931	-0.59	5.27	-80,736	13,596,236
2013-01-30	2013-01-28	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-16,660	2,595,251	-0.64	5.40	-89,964	14,014,355
2013-01-30	2013-01-29	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-260	44,020	-0.59	5.27	-1,370	231,985
2013-01-30	2013-01-28	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-282	44,280	-0.63	5.40	-1,523	239,112
2013-01-30	2013-01-29	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-47,247	7,956,988	-0.59	5.27	-248,992	41,933,327
2013-01-30	2013-01-28	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-51,377	8,004,235	-0.64	5.40	-277,436	43,222,869
2013-01-30	2013-01-29	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-507	85,271	-0.59	5.27	-2,672	449,378
2013-01-30	2013-01-28	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-551	85,778	-0.64	5.40	-2,975	463,201
2013-01-28	2013-01-25	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-13,790	2,611,911	-0.53	5.38	-74,190	14,052,081
2013-01-28	2013-01-24	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-36,324	2,625,701	-1.36	5.45	-197,966	14,310,070
2013-01-28	2013-01-25	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-234	44,562	-0.52	5.38	-1,259	239,744
2013-01-28	2013-01-24	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-616	44,796	-1.36	5.45	-3,357	244,138
2013-01-28	2013-01-25	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-456	86,329	-0.53	5.38	-2,453	464,450
2013-01-28	2013-01-24	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-1,201	86,785	-1.36	5.45	-6,545	472,978
2013-01-28	2013-01-25	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-42,525	8,055,612	-0.53	5.38	-228,784	43,339,193
2013-01-28	2013-01-24	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-111,022	8,098,137	-1.35	5.45	-605,070	44,134,847
2013-01-24	2013-01-23	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-25,354	2,662,025	-0.94	5.11	-129,559	13,602,948
2013-01-24	2013-01-22	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-14,966	2,687,379	-0.55	5.02	-75,129	13,490,643
2013-01-24	2013-01-23	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-430	45,412	-0.94	5.11	-2,197	232,055
2013-01-24	2013-01-22	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-254	45,842	-0.55	5.02	-1,275	230,127
2013-01-24	2013-01-23	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-839	87,986	-0.94	5.11	-4,287	449,608
2013-01-24	2013-01-22	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-495	88,825	-0.55	5.02	-2,485	445,902
2013-01-24	2013-01-23	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-78,188	8,210,159	-0.94	5.11	-399,541	41,953,912
2013-01-24	2013-01-22	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-46,153	8,288,347	-0.55	5.02	-231,688	41,607,502
2013-01-22	2013-01-18	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-19,080	2,702,345	-0.70	5.19	-99,025	14,025,171
2013-01-22	2013-01-17	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-12,615	2,721,425	-0.46	5.35	-67,490	14,559,624
2013-01-22	2013-01-18	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-324	46,096	-0.70	5.19	-1,682	239,238
2013-01-22	2013-01-17	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-214	46,420	-0.46	5.35	-1,145	248,347
2013-01-22	2013-01-18	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-58,838	8,334,500	-0.70	5.19	-305,369	43,256,055
2013-01-22	2013-01-17	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-38,903	8,393,338	-0.46	5.35	-208,131	44,904,358
2013-01-22	2013-01-18	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-631	89,320	-0.70	5.19	-3,275	463,571
2013-01-22	2013-01-17	4	CADX	CADENCE PHARMACEUTICALS INC Common Stock	S - Sale	X	-418	89,951	-0.46	5.35	-2,236	481,238
2013-01-18	2013-01-18	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock	J - Other		66,462	159,896	71.13
2013-01-18	2013-01-18	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock	J - Other		-1,000,000	5,772,968	-14.76
2013-01-15		3	NONE	Celator Pharmaceuticals Inc Common Stock				2,222,175
2013-01-15		3	NONE	Celator Pharmaceuticals Inc Common Stock				16,733
2013-01-15		3	NONE	Celator Pharmaceuticals Inc Common Stock				5,868
2012-07-24	2012-07-24	4	DRTX	Durata Therapeutics, Inc. Series A Preferred Stock	C - Conversion		-16,529	0	-100.00
2012-07-24	2012-07-24	4	DRTX	Durata Therapeutics, Inc. Series A Preferred Stock	C - Conversion		-2,227,596	0	-100.00
2012-07-24	2012-07-24	4	DRTX	Durata Therapeutics, Inc. Common Stock	P - Purchase		5,777	22,306	34.95	9.00	51,993	200,754
2012-07-24	2012-07-24	4	DRTX	Durata Therapeutics, Inc. Common Stock	C - Conversion		16,529	16,529
2012-07-24	2012-07-24	4	DRTX	Durata Therapeutics, Inc. Common Stock	P - Purchase		778,536	3,006,132	34.95	9.00	7,006,824	27,055,188
2012-07-24	2012-07-24	4	DRTX	Durata Therapeutics, Inc. Common Stock	C - Conversion		2,227,596	2,227,596
2012-07-18		3	DRTX	Durata Therapeutics, Inc. Common Stock				6,250
2012-06-12	2012-06-07	4	OREX	Orexigen Therapeutics, Inc. Stock Option (Right to Buy)	A - Award		35,000	35,000
2012-06-04	2012-05-31	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock	J - Other		93,434	93,434
2012-06-04	2012-05-31	4	ACHN	ACHILLION PHARMACEUTICALS INC Common Stock	J - Other		-1,200,000	6,772,968	-15.05
2012-05-22	2012-05-21	4	RVA	REVA Medical, Inc. Stock Option (Right to Buy)	A - Award		12,500	12,500
2012-03-27	2012-03-23	4	RVA	REVA Medical, Inc. Common Stock	S - Sale		-39,136	85,186	-31.48	5.16	-201,942	439,560
2012-03-27	2012-03-23	4	RVA	REVA Medical, Inc. Common Stock	S - Sale		-1,656,581	3,606,002	-31.48	5.16	-8,547,958	18,606,970

गैर-डेरिवेटिव या डेरिवेटिव प्रतिभूति की खुला बाज़ार या निजी खरीद

गैर-डेरिवेटिव या डेरिवेटिव प्रतिभूति का खुला बाज़ार या निजी बिक्री

कंपनी से प्रतिभूतियों का अनुदान, पुरस्कार या अन्य अधिग्रहण (जैसे एक ऑप्शन)

डेरिवेटिव का रूपांतरण

कंपनी को प्रतिभूतियों की बिक्री या हस्तांतरण

कंपनी से प्राप्त प्रतिभूतियों के हिस्से का उपयोग करके एक्सरसाइज मूल्य या कर दायित्व का भुगतान

इनसाइडर द्वारा या उसे प्रतिभूतियों का उपहार

इक्विटी स्वैप और समान हेजिंग लेनदेन

कंपनी से प्राप्त डेरिवेटिव प्रतिभूति के एक्सरसाइज या रूपांतरण (जैसे कि एक ऑप्शन)

किसी लेन-देन को स्वेच्छा से फॉर्म 4 पर रिपोर्ट किया गया

अन्य (लेन-देन का वर्णन करने वाले फ़ुटनोट के साथ)